BREAKTHROUGH T1D: Form 990, tax year 2016
View the entire original 990 at ProPublica ↗
- Organization
- BREAKTHROUGH T1D (EIN 23-1907729)
- Tax period
- 2016-07-01 to 2017-06-30
- Filed
- 2017-12-20
- IRS object ID
- 201723549349300112
- Schema version
- 2016v3.1
- Source
- Download XML · Original 990 at ProPublica
Every field in the e-filed return. Faint text is the IRS element name, for citing.
- Return header
- Form 990
- Schedule A
- Schedule C
- Schedule D
- Schedule F
- Schedule G
- Schedule I
- Schedule J
- Schedule L
- Schedule M
- Schedule O
- Schedule R
Return header ReturnHeader
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return | 2017-12-20T10:09:44-06:00 | ReturnTs |
| Tax Period End | 2017-06-30 | TaxPeriodEndDt |
Preparer Firm PreparerFirmGrp
Preparer Firm Name PreparerFirmName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | KPMG LLP | BusinessNameLine1Txt |
Preparer US Address PreparerUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 345 PARK AVE | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 10154 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Return Type | 990 | ReturnTypeCd |
| Tax Period Begin | 2016-07-01 | TaxPeriodBeginDt |
Filer Filer
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 231907729 | EIN |
Business Name BusinessName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | JDRF INTERNATIONAL | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| In Care Of | % GARY CURTO C/O JDRF INT | InCareOfNm |
| Business Name Control | JDRF | BusinessNameControlTxt |
| Phone | 2127859500 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 26 BROADWAY 15TH FL | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 10004 | ZIPCd |
Business Officer BusinessOfficerGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | MARK GREENE | PersonNm |
| Person Title | CFO | PersonTitleTxt |
| Phone | 6468734311 | PhoneNum |
| Signature | 2017-12-20 | SignatureDt |
| Discuss With Paid Preparer | Yes (true) | DiscussWithPaidPreparerInd |
Preparer Person PreparerPersonGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Preparer Person | DEVIN L DUNCAN | PreparerPersonNm |
| PTIN | P01249521 | PTIN |
| Phone | 2127859700 | PhoneNum |
| Preparation | 2017-12-18 | PreparationDt |
Filing Security Information FilingSecurityInformation
IP Address IPAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| I Pv4 Address | 167.68.102.5 | IPv4AddressTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Federal Original Submission Id | 20543020173545000000 | FederalOriginalSubmissionId |
| Federal Original Submission Id | 2017-12-20 | FederalOriginalSubmissionIdDt |
| Filing License Type | P | FilingLicenseTypeCd |
| At Submission Creation Device Id | E665B3E7A8D0C3A51E67724EBAB5121B0EE8EB14 | AtSubmissionCreationDeviceId |
| At Submission Filing Device Id | BBEE8D8720ADAD65542A46A6E57F18F679A29BCD | AtSubmissionFilingDeviceId |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Tax | 2016 | TaxYr |
| Build TS | 2018-03-14 21:41:22Z | BuildTS |
Form 990 IRS990
| Field | Value | IRS element (for citing) |
|---|---|---|
| Principal Officer | DEREK RAPP | PrincipalOfficerNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 26 BROADWAY 14TH FLOOR | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 10004 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Receipts | $230,050,266 | GrossReceiptsAmt |
| Group Return For Affiliates | false | GroupReturnForAffiliatesInd |
| Organization501c3 | Yes (X) | Organization501c3Ind |
| Website Address | www.jdrf.org | WebsiteAddressTxt |
| Type Of Organization Corp | Yes (X) | TypeOfOrganizationCorpInd |
| Formation | 1970 | FormationYr |
| Legal Domicile State | PA | LegalDomicileStateCd |
| Activity Or Mission | Accelerating life-changing breakthroughs to cure, prevent and treat Type 1 Diabetes and its complications. SEE SCHEDULE O | ActivityOrMissionDesc |
| Voting Members Governing Body | 33 | VotingMembersGoverningBodyCnt |
| Voting Members Independent | 31 | VotingMembersIndependentCnt |
| Total Employee | 886 | TotalEmployeeCnt |
| Total Volunteers | 300000 | TotalVolunteersCnt |
| Total Gross UBI | $45,150 | TotalGrossUBIAmt |
| Net Unrelated Bus Txbl Incm | $33,150 | NetUnrelatedBusTxblIncmAmt |
| PY Contributions Grants | $196,804,267 | PYContributionsGrantsAmt |
| CY Contributions Grants | $199,896,852 | CYContributionsGrantsAmt |
| PY Program Service Revenue | $0 | PYProgramServiceRevenueAmt |
| CY Program Service Revenue | $0 | CYProgramServiceRevenueAmt |
| PY Investment Income | $6,524,427 | PYInvestmentIncomeAmt |
| CY Investment Income | $1,227,269 | CYInvestmentIncomeAmt |
| PY Other Revenue | $1,027,088 | PYOtherRevenueAmt |
| CY Other Revenue | $1,129,676 | CYOtherRevenueAmt |
| PY Total Revenue | $204,355,782 | PYTotalRevenueAmt |
| CY Total Revenue | $202,253,797 | CYTotalRevenueAmt |
| PY Grants And Similar Paid | $75,084,432 | PYGrantsAndSimilarPaidAmt |
| CY Grants And Similar Paid | $79,009,656 | CYGrantsAndSimilarPaidAmt |
| PY Benefits Paid To Members | $0 | PYBenefitsPaidToMembersAmt |
| CY Benefits Paid To Members | $0 | CYBenefitsPaidToMembersAmt |
| PY Salaries Comp Emp Bnft Paid | $74,149,309 | PYSalariesCompEmpBnftPaidAmt |
| CY Salaries Comp Emp Bnft Paid | $75,347,284 | CYSalariesCompEmpBnftPaidAmt |
| PY Total Prof Fndrsng Expns | $0 | PYTotalProfFndrsngExpnsAmt |
| CY Total Prof Fndrsng Expns | $0 | CYTotalProfFndrsngExpnsAmt |
| CY Total Fundraising Expense | $25,764,003 | CYTotalFundraisingExpenseAmt |
| PY Other Expenses | $40,245,664 | PYOtherExpensesAmt |
| CY Other Expenses | $39,432,392 | CYOtherExpensesAmt |
| PY Total Expenses | $189,479,405 | PYTotalExpensesAmt |
| CY Total Expenses | $193,789,332 | CYTotalExpensesAmt |
| PY Revenues Less Expenses | $14,876,377 | PYRevenuesLessExpensesAmt |
| CY Revenues Less Expenses | $8,464,465 | CYRevenuesLessExpensesAmt |
| Total Assets BOY | $197,093,128 | TotalAssetsBOYAmt |
| Total Assets EOY | $198,753,573 | TotalAssetsEOYAmt |
| Total Liabilities BOY | $133,197,854 | TotalLiabilitiesBOYAmt |
| Total Liabilities EOY | $121,385,069 | TotalLiabilitiesEOYAmt |
| Net Assets Or Fund Balances BOY | $63,895,274 | NetAssetsOrFundBalancesBOYAmt |
| Net Assets Or Fund Balances EOY | $77,368,504 | NetAssetsOrFundBalancesEOYAmt |
| Info In Schedule O Part III | Yes (X) | InfoInScheduleOPartIIIInd |
| Mission | JDRFs mission is to accelerate life-changing breakthroughs to cure, prevent and treat Type 1 Diabetes (T1D) and its complications. JDRF is the leading global organization focused on T1D research and is committed to funding the development of new therapies and treatments to keep people with T1D healthier, longer, until a cure is found. Its strength lies in its exclusive focus and singular influence on the worldwide effort to end T1D. JDRF works every day to change the reality of this life-threatening autoimmune disease for millions of people - and to prevent anyone else from contracting the disease - by funding research, advocating for government support of research and new therapies, ensuring new therapies and technologies come to market, and connecting and engaging the T1D community. JDRF has funded more than $2 billion in research to date and made significant progress in understanding and fighting the disease. JDRF has played a role in nearly every T1D therapeutic advance of the past | MissionDesc |
| Significant New Program Srvc | false | SignificantNewProgramSrvcInd |
| Significant Change | false | SignificantChangeInd |
| Expense | $79,009,656 | ExpenseAmt |
| Grant | $79,009,656 | GrantAmt |
| Desc | RESEARCH FUNDING FOR THE FY17 PERIOD ENDING JUNE 30, 2017, JDRF DIRECTLY FUNDED RESEARCH GRANTS AND INDUSTRY AGREEMENTS FOR WHICH $79 MILLION IN RESEARCH GRANT NET EXPENSE WAS RECOGNIZED ACCORDING TO GAAP AND EXCLUDING $7.1 MILLION OF PROGRAMMATIC RESEARCH INVESTMENTS WHICH ARE RECORDED TO THE ORGANIZATIONS BALANCE SHEET. FOR AN EXPANDED DESCRIPTION OF PROGRAM SERVICE ACTIVITIES RELATED TO DIRECT RESEARCH FUNDING. SEE SCHEDULE O. | Desc |
Prog Srvc Accom Acty2 ProgSrvcAccomActy2Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $20,866,569 | ExpenseAmt |
| Desc | RESEARCH SUPPORT JDRF MAINTAINS AN IN-HOUSE TEAM OF SKILLED SCIENTIFIC, MEDICAL, POLICY AND GOVERNMENT RELATIONS PROFESSIONALS WHO PLAY A CRITICAL ROLE IN LEADING AND SUPPORTING THE EVALUATION OF RESEARCH FUNDING OPPORTUNITIES BY JDRF AND INFLUENCING RESEARCH DIRECTION AND THE DISBURSEMENT OF RESEARCH FUNDS FROM OTHERS. THESE PROFESSIONALS ALSO WORK WITH REGULATORY AND POLICY OFFICIALS TO ENSURE THAT RESEARCH CAN PROCEED WITHOUT DELAY AND RESULTS ARE UNDERSTOOD BY HEALTHCARE DECISION MAKERS. SEE SCHEDULE O. | Desc |
Prog Srvc Accom Acty3 ProgSrvcAccomActy3Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Expense | $52,763,561 | ExpenseAmt |
| Desc | PUBLIC EDUCATION AND OUTREACH JDRF EDUCATES THE COMMUNITY AND PROVIDES OUTREACH SERVICES TO NEWLY DIAGNOSED CHILDREN AND ADULTS, THEIR FAMILIES AND OTHERS ABOUT T1D AND ITS COMPLICATIONS. FOR AN EXPANDED DESCRIPTION OF PROGRAM SERVICE ACTIVITIES RELATED TO PUBLIC EDUCATION AND OUTREACH. SEE SCHEDULE O. | Desc |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Program Service Expenses | $152,639,786 | TotalProgramServiceExpensesAmt |
| Described In Section501c3 | Yes (true) | DescribedInSection501c3Ind |
| Schedule B Required | false | ScheduleBRequiredInd |
| Political Campaign Acty | false | PoliticalCampaignActyInd |
| Lobbying Activities | Yes (true) | LobbyingActivitiesInd |
| Subject To Proxy Tax | false | SubjectToProxyTaxInd |
| Donor Advised Fund | false | DonorAdvisedFundInd |
| Conservation Easements | false | ConservationEasementsInd |
| Collections Of Art | false | CollectionsOfArtInd |
| Credit Counseling | false | CreditCounselingInd |
| Temp Or Permanent Endowments | Yes (true) | TempOrPermanentEndowmentsInd |
| Report Land Building Equipment | Yes (true) | ReportLandBuildingEquipmentInd |
| Report Investments Other Sec | Yes (true) | ReportInvestmentsOtherSecInd |
| Report Program Related Invst | false | ReportProgramRelatedInvstInd |
| Report Other Assets | false | ReportOtherAssetsInd |
| Report Other Liabilities | Yes (true) | ReportOtherLiabilitiesInd |
| Include FIN48 Footnote | Yes (true) | IncludeFIN48FootnoteInd |
| Independent Audit Fincl Stmt | false | IndependentAuditFinclStmtInd |
| Consolidated Audit Fincl Stmt | Yes (true) | ConsolidatedAuditFinclStmtInd |
| School Operating | false | SchoolOperatingInd |
| Foreign Office | Yes (true) | ForeignOfficeInd |
| Foreign Activities | Yes (true) | ForeignActivitiesInd |
| More Than5000 K To Org | Yes (true) | MoreThan5000KToOrgInd |
| More Than5000 K To Individuals | false | MoreThan5000KToIndividualsInd |
| Professional Fundraising | Yes (true) | ProfessionalFundraisingInd |
| Fundraising Activities | Yes (true) | FundraisingActivitiesInd |
| Gaming Activities | Yes (true) | GamingActivitiesInd |
| Operate Hospital | false | OperateHospitalInd |
| Grants To Organizations | Yes (true) | GrantsToOrganizationsInd |
| Grants To Individuals | false | GrantsToIndividualsInd |
| Schedule J Required | Yes (true) | ScheduleJRequiredInd |
| Tax Exempt Bonds | false | TaxExemptBondsInd |
| Engaged In Excess Benefit Trans | false | EngagedInExcessBenefitTransInd |
| PY Excess Benefit Trans | false | PYExcessBenefitTransInd |
| Loan Outstanding | false | LoanOutstandingInd |
| Grant To Related Person | false | GrantToRelatedPersonInd |
| Business Rln With Org Mem | false | BusinessRlnWithOrgMemInd |
| Business Rln With Fam Mem | Yes (true) | BusinessRlnWithFamMemInd |
| Business Rln With Officer Ent | false | BusinessRlnWithOfficerEntInd |
| Deductible Non Cash Contri | Yes (true) | DeductibleNonCashContriInd |
| Deductible Art Contribution | false | DeductibleArtContributionInd |
| Terminate Operations | false | TerminateOperationsInd |
| Partial Liquidation | false | PartialLiquidationInd |
| Disregarded Entity | Yes (true) | DisregardedEntityInd |
| Related Entity | Yes (true) | RelatedEntityInd |
| Related Organization Ctrl Ent | Yes (true) | RelatedOrganizationCtrlEntInd |
| Transaction With Control Ent | false | TransactionWithControlEntInd |
| Trnsfr Exmpt Non Chrtbl Rltd Org | false | TrnsfrExmptNonChrtblRltdOrgInd |
| Activities Conducted Prtshp | false | ActivitiesConductedPrtshpInd |
| Schedule O Required | Yes (true) | ScheduleORequiredInd |
| Info In Schedule O Part V | Yes (X) | InfoInScheduleOPartVInd |
| IRP Document | 964 | IRPDocumentCnt |
| IRP Document W2 G | 6 | IRPDocumentW2GCnt |
| Backup Wthld Compliance | Yes (true) | BackupWthldComplianceInd |
| Employee | 886 | EmployeeCnt |
| Employment Tax Returns Filed | Yes (true) | EmploymentTaxReturnsFiledInd |
| Unrelated Bus Incm Over Limit | Yes (true) | UnrelatedBusIncmOverLimitInd |
| Form990 T Filed | Yes (true) | Form990TFiledInd |
| Foreign Financial Account | Yes (true) | ForeignFinancialAccountInd |
| Foreign Country | IS | ForeignCountryCd |
| Foreign Country | DA | ForeignCountryCd |
| Foreign Country | NL | ForeignCountryCd |
| Prohibited Tax Shelter Trans | false | ProhibitedTaxShelterTransInd |
| Taxable Party Notification | false | TaxablePartyNotificationInd |
| Nondeductible Contributions | false | NondeductibleContributionsInd |
| Quid Pro Quo Contributions | Yes (true) | QuidProQuoContributionsInd |
| Quid Pro Quo Contri Discl | Yes (true) | QuidProQuoContriDisclInd |
| Form8282 Property Disposed Of | false | Form8282PropertyDisposedOfInd |
| Rcv Fnds To Pay Prsnl Bnft Cntrct | false | RcvFndsToPayPrsnlBnftCntrctInd |
| Pay Premiums Prsnl Bnft Cntrct | false | PayPremiumsPrsnlBnftCntrctInd |
| Form1098 C Filed | Yes (true) | Form1098CFiledInd |
| Indoor Tanning Services | false | IndoorTanningServicesInd |
| Info In Schedule O Part VI | Yes (X) | InfoInScheduleOPartVIInd |
| Governing Body Voting Members | 33 | GoverningBodyVotingMembersCnt |
| Independent Voting Member | 31 | IndependentVotingMemberCnt |
| Family Or Business Rln | false | FamilyOrBusinessRlnInd |
| Delegation Of Mgmt Duties | false | DelegationOfMgmtDutiesInd |
| Change To Org Documents | false | ChangeToOrgDocumentsInd |
| Material Diversion Or Misuse | false | MaterialDiversionOrMisuseInd |
| Members Or Stockholders | false | MembersOrStockholdersInd |
| Election Of Board Members | false | ElectionOfBoardMembersInd |
| Decisions Subject To Approva | false | DecisionsSubjectToApprovaInd |
| Minutes Of Governing Body | Yes (true) | MinutesOfGoverningBodyInd |
| Minutes Of Committees | Yes (true) | MinutesOfCommitteesInd |
| Officer Mailing Address | false | OfficerMailingAddressInd |
| Local Chapters | Yes (true) | LocalChaptersInd |
| Policies Reference Chapters | Yes (true) | PoliciesReferenceChaptersInd |
| Form990 Provided To Gvrn Body | Yes (true) | Form990ProvidedToGvrnBodyInd |
| Conflict Of Interest Policy | Yes (true) | ConflictOfInterestPolicyInd |
| Annual Disclosure Covered Prsn | Yes (true) | AnnualDisclosureCoveredPrsnInd |
| Regular Monitoring Enfrc | Yes (true) | RegularMonitoringEnfrcInd |
| Whistleblower Policy | Yes (true) | WhistleblowerPolicyInd |
| Document Retention Policy | Yes (true) | DocumentRetentionPolicyInd |
| Compensation Process CEO | Yes (true) | CompensationProcessCEOInd |
| Compensation Process Other | Yes (true) | CompensationProcessOtherInd |
| Investment In Joint Venture | Yes (true) | InvestmentInJointVentureInd |
| Written Policy Or Procedure | Yes (true) | WrittenPolicyOrProcedureInd |
| States Where Copy Of Return Is Fld | AL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AK | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AZ | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | AR | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CO | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | CT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | DE | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | DC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | FL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | GA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | HI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | ID | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | IL | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | IN | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | IA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | KS | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | KY | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | LA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | ME | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MD | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MN | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MS | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MO | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | MT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NE | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NV | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NH | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NJ | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NM | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NY | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | NC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | ND | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OH | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OK | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | OR | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | PA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | RI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | SC | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | SD | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | TN | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | TX | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | UT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | VT | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | VA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WA | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WV | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WI | StatesWhereCopyOfReturnIsFldCd |
| States Where Copy Of Return Is Fld | WY | StatesWhereCopyOfReturnIsFldCd |
| Own Website | Yes (X) | OwnWebsiteInd |
| Upon Request | Yes (X) | UponRequestInd |
Books In Care Of Detail BooksInCareOfDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | GARY CURTO CO JDRF INT | PersonNm |
| Phone | 2124797551 | PhoneNum |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 26 BROADWAY 1TH FL | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 10004 | ZIPCd |
Form990 Part VII Section A Form990PartVIISectionAGrp (43 entries)
| TitleTitleTxt | Average Hours Per WeekAverageHoursPerWeekRt | Average Hours Per Week Rltd OrgAverageHoursPerWeekRltdOrgRt | Individual Trustee Or DirectorIndividualTrusteeOrDirectorInd | Reportable Comp From OrgReportableCompFromOrgAmt | Reportable Comp From Rltd OrgReportableCompFromRltdOrgAmt | Other CompensationOtherCompensationAmt | OfficerOfficerInd | Key EmployeeKeyEmployeeInd | Highest Compensated EmployeeHighestCompensatedEmployeeInd |
|---|---|---|---|---|---|---|---|---|---|
| MAARTEN DE GROOT FY15-17 | |||||||||
| BOARD MEMBER | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| LORNE SHIFF FY15-17 | |||||||||
| BOARD MEMBER | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| NICOLE JOHNSON FY16-17 | |||||||||
| BOARD MEMBER | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| MIKE LEE FY16-18 | |||||||||
| BOARD MEMBER | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| LARRY SOLER FY16-18 | |||||||||
| SECRETARY/CHAIR, NOM & GOV | 7.0 | 0.0 | Yes (X) | $0 | $0 | $0 | Yes (X) | ||
| WENDY WOOD FY16-18 | |||||||||
| BOARD MEMBER | 5.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| NANETTE DETURK FY17-19 | |||||||||
| BOARD MEMBER | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| MICHELLE GRIFFIN FY17-19 | |||||||||
| CHAIR, DEVELOPMENT | 7.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| STEPHEN NEWMAN MD FY17-19 | |||||||||
| CHAIR, RESEARCH | 7.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| LISA ALTMAN FY15-17 | |||||||||
| BOARD MEMBER | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| GRANT BEARD FY15-17 | |||||||||
| TREASURER/CHAIR, FINANCE | 7.0 | 0.0 | Yes (X) | $0 | $0 | $0 | Yes (X) | ||
| RANDY ANDERSON FY15-17 | |||||||||
| BOARD MEMBER | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| TIMOTHY CLARK FY15-17 | |||||||||
| CHAIR, INVESTMENT | 7.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| MARK FISCHER-COLBRIE FY16-18 | |||||||||
| CHAIRMAN OF THE BOARD | 20.0 | 0.0 | Yes (X) | $0 | $0 | $0 | Yes (X) | ||
| SCOTT MCCORMICK FY15-17 | |||||||||
| BOARD MEMBER | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| LISA REED FY15-17 | |||||||||
| BOARD MEMBER | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| RED MAXWELL FY15-17 | |||||||||
| BOARD MEMBER | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| MARVIN DAITCH FY16-18 | |||||||||
| BOARD MEMBER | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| PAM EDMONDS FY16-18 | |||||||||
| CHAIR, ADVOCACY | 7.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| PAT MCFEELEY FY16-17 | |||||||||
| CHAIR, CHANCELLORS | 7.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| JEFF PLUMER FY16-18 | |||||||||
| CHAIR, AUDIT | 7.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| LORRAINE STIEHL FY15-17 | |||||||||
| BOARD MEMBER | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| LISA WALLACK FY16-18 | |||||||||
| BOARD MEMBER | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| SEAN DOHERTY FY17-19 | |||||||||
| CHAIR, JDRF T1D FUND LLC | 7.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| PAUL HEATH FY17-19 | |||||||||
| BOARD MEMBER | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| KAREN JORDAN FY17-19 | |||||||||
| BOARD MEMBER | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| JOHN KAMPFE FY17-19 | |||||||||
| BOARD MEMBER | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| ELLEN LEAKE FY17-19 | |||||||||
| BOARD VICE-CHAIR | 10.0 | 0.0 | Yes (X) | $0 | $0 | $0 | Yes (X) | ||
| DOUG LOWENSTEIN FY17-19 | |||||||||
| BOARD MEMBER | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| DAYTON OGDEN FY17-19 | |||||||||
| CHAIR, TALENT & COMPENSATION | 7.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| ANGIE PLATT FY17-19 | |||||||||
| BOARD MEMBER | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| JERRY WISLER FY17-19 | |||||||||
| BOARD MEMBER | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| KAREY L WITTY FY17-19 | |||||||||
| BOARD MEMBER | 3.0 | 0.0 | Yes (X) | $0 | $0 | $0 | |||
| DEREK RAPP | |||||||||
| PRESIDENT AND CEO | 50.0 | 0.0 | $725,000 | $0 | $48,715 | Yes (X) | |||
| SANDRA HIJIKATA | |||||||||
| CHIEF DEV OFFICER & ASST. SECY | 50.0 | 0.0 | $368,333 | $0 | $18,280 | Yes (X) | |||
| MARK GREENE | |||||||||
| CFO & ASST. TRES | 50.0 | 0.0 | $363,125 | $0 | $22,288 | Yes (X) | |||
| JILL CLARK | |||||||||
| CHIEF OF STAFF & ASST. SECY | 50.0 | 0.0 | $240,831 | $0 | $14,703 | Yes (X) | |||
| JONATHAN R BEHR | |||||||||
| MANAGING DIRECTOR JDRF-T1D FND | 50.0 | 0.0 | $25,000 | $0 | $0 | Yes (X) | |||
| JULIA GREENSTEIN | |||||||||
| VP RESEARCH | 50.0 | 0.0 | $282,800 | $0 | $14,613 | Yes (X) | |||
| AARON KOWALSKI | |||||||||
| CHIEF MISSION OFFICER | 50.0 | 0.0 | $350,000 | $0 | $35,661 | Yes (X) | |||
| RICHARD INSEL ENDED 63016 | |||||||||
| CHIEF SCIENTIFIC OFFICER | 50.0 | 0.0 | $605,102 | $0 | $27,345 | Yes (X) | |||
| MARGO LUCERO | |||||||||
| SVP CORPORATE DEVELOPMENT | 50.0 | 0.0 | $268,000 | $0 | $38,273 | Yes (X) | |||
| STEVEN GRIFFEN MD | |||||||||
| SVP RESEARCH | 50.0 | 0.0 | $377,033 | $0 | $42,547 | Yes (X) | |||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Reportable Comp From Org | $3,605,224 | TotalReportableCompFromOrgAmt |
| Tot Reportable Comp Rltd Org | $0 | TotReportableCompRltdOrgAmt |
| Total Other Compensation | $262,425 | TotalOtherCompensationAmt |
| Indiv Rcvd Greater Than100 K | 149 | IndivRcvdGreaterThan100KCnt |
| Former Ofcr Employees Listed | false | FormerOfcrEmployeesListedInd |
| Total Comp Greater Than150 K | Yes (true) | TotalCompGreaterThan150KInd |
| Compensation From Other Srcs | false | CompensationFromOtherSrcsInd |
Contractor Compensation ContractorCompensationGrp (5 entries)
| Address Line1ContractorAddress/ForeignAddress/AddressLine1Txt | CityContractorAddress/ForeignAddress/CityNm | Province Or StateContractorAddress/ForeignAddress/ProvinceOrStateNm | CountryContractorAddress/ForeignAddress/CountryCd | ServicesServicesDesc | CompensationCompensationAmt | Address Line1ContractorAddress/USAddress/AddressLine1Txt | CityContractorAddress/USAddress/CityNm | State AbbreviationContractorAddress/USAddress/StateAbbreviationCd | ZIPContractorAddress/USAddress/ZIPCd |
|---|---|---|---|---|---|---|---|---|---|
| SIX DEGREES MEDICAL CONSULTING | |||||||||
| 175 BLOOR ST | TORONTO | 0 | CA | FACULTY TRAINING | $578,850 | ||||
| 10UP LLC | |||||||||
| WEB DEVELOPMENT | $567,981 | 2765 CARRADALE DR | ROSEVILLE | CA | 95661 | ||||
| CDS GLOBAL | |||||||||
| 3RD PARTY LOCK BOX | $542,650 | 1901 BELL AVE | DES MOINES | IA | 50315 | ||||
| STRAIGHTLINE INTERNATIONAL | |||||||||
| PROGRAMMING SERVICES | $457,810 | 107 GRAND STREET 6 | NEW YORK | NY | 10013 | ||||
| STOKES AUCTION GROUP | |||||||||
| AUCTIONEER SERVICES | $350,750 | 740 MUNEVAR DR | CARIDIFF BY THE SEA | CA | 92007 | ||||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct Rcvd Greater Than100 K | 39 | CntrctRcvdGreaterThan100KCnt |
| Federated Campaigns | $4,488,030 | FederatedCampaignsAmt |
| Fundraising | $127,671,682 | FundraisingAmt |
| All Other Contributions | $67,737,140 | AllOtherContributionsAmt |
| Noncash Contributions | $17,224,248 | NoncashContributionsAmt |
| Total Contributions | $199,896,852 | TotalContributionsAmt |
| Total Program Service Revenue | $0 | TotalProgramServiceRevenueAmt |
Investment Income InvestmentIncomeGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $593,975 | TotalRevenueColumnAmt |
| Unrelated Business Revenue | $45,150 | UnrelatedBusinessRevenueAmt |
| Exclusion | $548,825 | ExclusionAmt |
Incm From Invest Bond Proceeds IncmFromInvestBondProceedsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Royalties Revenue RoyaltiesRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Rental Income Or Loss RentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Real | $0 | RealAmt |
| Personal | $0 | PersonalAmt |
Net Rental Income Or Loss NetRentalIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Gross Amount Sales Assets GrossAmountSalesAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $1,017,000 | SecuritiesAmt |
Less Cost Oth Basis Sales Expnss LessCostOthBasisSalesExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $383,706 | SecuritiesAmt |
Gain Or Loss GainOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities | $633,294 | SecuritiesAmt |
Net Gain Or Loss Investments NetGainOrLossInvestmentsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $633,294 | TotalRevenueColumnAmt |
| Exclusion | $633,294 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Fundraising Gross Income | $27,152,973 | FundraisingGrossIncomeAmt |
| Contri Rpt Fundraising Event | $127,671,682 | ContriRptFundraisingEventAmt |
| Fundraising Direct Expenses | $27,152,973 | FundraisingDirectExpensesAmt |
| Gaming Gross Income | $1,106,452 | GamingGrossIncomeAmt |
| Gaming Direct Expenses | $259,790 | GamingDirectExpensesAmt |
Net Income From Gaming NetIncomeFromGamingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $846,662 | TotalRevenueColumnAmt |
| Exclusion | $846,662 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Sales Of Inventory | $0 | GrossSalesOfInventoryAmt |
| Cost Of Goods Sold | $0 | CostOfGoodsSoldAmt |
Net Income Or Loss NetIncomeOrLossGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $0 | TotalRevenueColumnAmt |
Other Revenue Misc OtherRevenueMiscGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | MISCELLANEOUS PROGRAM REVENUE | Desc |
| Business | 900099 | BusinessCd |
| Total Revenue Column | $283,014 | TotalRevenueColumnAmt |
| Exclusion | $283,014 | ExclusionAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Revenue Total | $283,014 | OtherRevenueTotalAmt |
Total Revenue TotalRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Revenue Column | $202,253,797 | TotalRevenueColumnAmt |
| Unrelated Business Revenue | $45,150 | UnrelatedBusinessRevenueAmt |
| Exclusion | $2,311,795 | ExclusionAmt |
Grants To Domestic Orgs GrantsToDomesticOrgsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $56,018,820 | TotalAmt |
| Program Services | $56,018,820 | ProgramServicesAmt |
Grants To Domestic Individuals GrantsToDomesticIndividualsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Foreign Grants ForeignGrantsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $22,990,836 | TotalAmt |
| Program Services | $22,990,836 | ProgramServicesAmt |
Benefits To Members BenefitsToMembersGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Comp Current Ofcr Directors CompCurrentOfcrDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,784,272 | TotalAmt |
| Program Services | $1,138,366 | ProgramServicesAmt |
| Management And General | $231,955 | ManagementAndGeneralAmt |
| Fundraising | $413,951 | FundraisingAmt |
Comp Disqual Persons CompDisqualPersonsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $108,774 | TotalAmt |
| Program Services | $74,292 | ProgramServicesAmt |
| Management And General | $14,141 | ManagementAndGeneralAmt |
| Fundraising | $20,341 | FundraisingAmt |
Other Salaries And Wages OtherSalariesAndWagesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $58,996,885 | TotalAmt |
| Program Services | $37,635,118 | ProgramServicesAmt |
| Management And General | $7,669,595 | ManagementAndGeneralAmt |
| Fundraising | $13,692,172 | FundraisingAmt |
Pension Plan Contributions PensionPlanContributionsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,467,676 | TotalAmt |
| Program Services | $936,377 | ProgramServicesAmt |
| Management And General | $190,798 | ManagementAndGeneralAmt |
| Fundraising | $340,501 | FundraisingAmt |
Other Employee Benefits OtherEmployeeBenefitsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $8,952,280 | TotalAmt |
| Program Services | $5,711,555 | ProgramServicesAmt |
| Management And General | $1,163,796 | ManagementAndGeneralAmt |
| Fundraising | $2,076,929 | FundraisingAmt |
Payroll Taxes PayrollTaxesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $4,037,397 | TotalAmt |
| Program Services | $2,794,875 | ProgramServicesAmt |
| Management And General | $646,918 | ManagementAndGeneralAmt |
| Fundraising | $595,604 | FundraisingAmt |
Fees For Services Management FeesForServicesManagementGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,475,007 | TotalAmt |
| Program Services | $1,035,136 | ProgramServicesAmt |
| Management And General | $134,882 | ManagementAndGeneralAmt |
| Fundraising | $304,989 | FundraisingAmt |
Fees For Services Legal FeesForServicesLegalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $673,601 | TotalAmt |
| Program Services | $569,193 | ProgramServicesAmt |
| Management And General | $33,680 | ManagementAndGeneralAmt |
| Fundraising | $70,728 | FundraisingAmt |
Fees For Services Accounting FeesForServicesAccountingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $233,403 | TotalAmt |
| Program Services | $197,226 | ProgramServicesAmt |
| Management And General | $11,670 | ManagementAndGeneralAmt |
| Fundraising | $24,507 | FundraisingAmt |
Fees For Services Lobbying FeesForServicesLobbyingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $623,411 | TotalAmt |
| Program Services | $623,411 | ProgramServicesAmt |
Fees For Services Prof Fundraising FeesForServicesProfFundraising
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Fees For Srvc Invst Mgmnt Fees FeesForSrvcInvstMgmntFeesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $452,370 | TotalAmt |
| Management And General | $452,370 | ManagementAndGeneralAmt |
Fees For Services Other FeesForServicesOtherGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $3,166,685 | TotalAmt |
| Program Services | $2,675,849 | ProgramServicesAmt |
| Management And General | $158,334 | ManagementAndGeneralAmt |
| Fundraising | $332,502 | FundraisingAmt |
Advertising AdvertisingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $5,167,896 | TotalAmt |
| Program Services | $2,756,198 | ProgramServicesAmt |
| Management And General | $432,525 | ManagementAndGeneralAmt |
| Fundraising | $1,979,173 | FundraisingAmt |
Office Expenses OfficeExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $1,188,854 | TotalAmt |
| Program Services | $722,823 | ProgramServicesAmt |
| Management And General | $205,672 | ManagementAndGeneralAmt |
| Fundraising | $260,359 | FundraisingAmt |
Information Technology InformationTechnologyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $3,941,474 | TotalAmt |
| Program Services | $2,396,416 | ProgramServicesAmt |
| Management And General | $681,875 | ManagementAndGeneralAmt |
| Fundraising | $863,183 | FundraisingAmt |
Royalties RoyaltiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Occupancy OccupancyGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $8,313,000 | TotalAmt |
| Program Services | $5,026,204 | ProgramServicesAmt |
| Management And General | $1,439,436 | ManagementAndGeneralAmt |
| Fundraising | $1,847,360 | FundraisingAmt |
Travel TravelGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,413,804 | TotalAmt |
| Program Services | $1,734,318 | ProgramServicesAmt |
| Management And General | $229,794 | ManagementAndGeneralAmt |
| Fundraising | $449,692 | FundraisingAmt |
Pymt Travel Entrtnmnt Pub Ofcl PymtTravelEntrtnmntPubOfclGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Conferences Meetings ConferencesMeetingsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,696,865 | TotalAmt |
| Program Services | $1,966,015 | ProgramServicesAmt |
| Management And General | $256,202 | ManagementAndGeneralAmt |
| Fundraising | $474,648 | FundraisingAmt |
Interest InterestGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Payments To Affiliates PaymentsToAffiliatesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Depreciation Depletion DepreciationDepletionGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $4,629,902 | TotalAmt |
| Program Services | $2,814,980 | ProgramServicesAmt |
| Management And General | $800,973 | ManagementAndGeneralAmt |
| Fundraising | $1,013,949 | FundraisingAmt |
Insurance InsuranceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $524,072 | TotalAmt |
| Program Services | $318,636 | ProgramServicesAmt |
| Management And General | $90,664 | ManagementAndGeneralAmt |
| Fundraising | $114,772 | FundraisingAmt |
Other Expenses OtherExpensesGrp (3 entries)
| DescDesc | TotalTotalAmt | Program ServicesProgramServicesAmt | Management And GeneralManagementAndGeneralAmt | FundraisingFundraisingAmt |
|---|---|---|---|---|
| OUTREACH EXPENSES | $2,021,589 | $1,286,944 | $277,766 | $456,879 |
| DUES & FEES | $1,492,960 | $950,418 | $205,133 | $337,409 |
| OTHER MISC EXPENSES | $417,499 | $265,780 | $57,364 | $94,355 |
Total Functional Expenses TotalFunctionalExpensesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $193,789,332 | TotalAmt |
| Program Services | $152,639,786 | ProgramServicesAmt |
| Management And General | $15,385,543 | ManagementAndGeneralAmt |
| Fundraising | $25,764,003 | FundraisingAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Joint Costs | Yes (X) | JointCostsInd |
Total Joint Costs TotalJointCostsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $2,105,461 | TotalAmt |
| Program Services | $743,506 | ProgramServicesAmt |
| Management And General | $111,868 | ManagementAndGeneralAmt |
| Fundraising | $1,250,087 | FundraisingAmt |
Cash Non Interest Bearing CashNonInterestBearingGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $30,314,175 | BOYAmt |
| EOY | $23,695,495 | EOYAmt |
Savings And Temp Cash Invst SavingsAndTempCashInvstGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $34,391,736 | BOYAmt |
| EOY | $30,545,972 | EOYAmt |
Pledges And Grants Receivable PledgesAndGrantsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $25,415,000 | BOYAmt |
| EOY | $28,143,186 | EOYAmt |
Accounts Receivable AccountsReceivableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $15,598,016 | BOYAmt |
| EOY | $14,274,402 | EOYAmt |
Receivables From Officers Etc ReceivablesFromOfficersEtcGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Rcvbl From Disqualified Prsn RcvblFromDisqualifiedPrsnGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Oth Notes Loans Receivable Net OthNotesLoansReceivableNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $5,000,000 | EOYAmt |
Inventories For Sale Or Use InventoriesForSaleOrUseGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Prepaid Expenses Defrd Charges PrepaidExpensesDefrdChargesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $4,604,817 | BOYAmt |
| EOY | $5,592,386 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Land Bldg Equip Cost Or Other Bss | $31,236,775 | LandBldgEquipCostOrOtherBssAmt |
| Land Bldg Equip Accum Deprec | $21,516,895 | LandBldgEquipAccumDeprecAmt |
Land Bldg Equip Basis Net LandBldgEquipBasisNetGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $13,589,735 | BOYAmt |
| EOY | $9,719,880 | EOYAmt |
Investments Pub Traded Sec InvestmentsPubTradedSecGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $34,442,190 | BOYAmt |
| EOY | $38,164,626 | EOYAmt |
Investments Other Securities InvestmentsOtherSecuritiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $36,283,061 | BOYAmt |
| EOY | $39,867,626 | EOYAmt |
Investments Program Related InvestmentsProgramRelatedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $2,454,398 | BOYAmt |
| EOY | $3,750,000 | EOYAmt |
Intangible Assets IntangibleAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Other Assets Total OtherAssetsTotalGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Total Assets TotalAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $197,093,128 | BOYAmt |
| EOY | $198,753,573 | EOYAmt |
Accounts Payable Accr Expnss AccountsPayableAccrExpnssGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $16,335,885 | BOYAmt |
| EOY | $16,729,137 | EOYAmt |
Grants Payable GrantsPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $105,778,368 | BOYAmt |
| EOY | $94,060,180 | EOYAmt |
Deferred Revenue DeferredRevenueGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $8,340,978 | BOYAmt |
| EOY | $7,934,693 | EOYAmt |
Tax Exempt Bond Liabilities TaxExemptBondLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Escrow Account Liability EscrowAccountLiabilityGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Loans From Officers Directors LoansFromOfficersDirectorsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Mortg Notes Pybl Scrd Invst Prop MortgNotesPyblScrdInvstPropGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Unsecured Notes Loans Payable UnsecuredNotesLoansPayableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $0 | BOYAmt |
| EOY | $0 | EOYAmt |
Other Liabilities OtherLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $2,742,623 | BOYAmt |
| EOY | $2,661,059 | EOYAmt |
Total Liabilities TotalLiabilitiesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $133,197,854 | BOYAmt |
| EOY | $121,385,069 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Organization Follows SFAS117 | Yes (X) | OrganizationFollowsSFAS117Ind |
Unrestricted Net Assets UnrestrictedNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $24,131,379 | BOYAmt |
| EOY | $39,586,000 | EOYAmt |
Temporarily Rstr Net Assets TemporarilyRstrNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $32,690,094 | BOYAmt |
| EOY | $30,441,504 | EOYAmt |
Permanently Rstr Net Assets PermanentlyRstrNetAssetsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $7,073,801 | BOYAmt |
| EOY | $7,341,000 | EOYAmt |
Total Net Assets Fund Balance TotalNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $63,895,274 | BOYAmt |
| EOY | $77,368,504 | EOYAmt |
Tot Liab Net Assets Fund Balance TotLiabNetAssetsFundBalanceGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| BOY | $197,093,128 | BOYAmt |
| EOY | $198,753,573 | EOYAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Reconcilation Revenue Expnss | $8,464,465 | ReconcilationRevenueExpnssAmt |
| Net Unrlzd Gains Losses Invst | $5,008,765 | NetUnrlzdGainsLossesInvstAmt |
| Method Of Accounting Accrual | Yes (X) | MethodOfAccountingAccrualInd |
| Accountant Compile Or Review | false | AccountantCompileOrReviewInd |
| FS Audited | Yes (true) | FSAuditedInd |
FS Audited Basis FSAuditedBasisGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Consolidated Basis Fincl Stmt | Yes (X) | ConsolidatedBasisFinclStmtInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Audit Committee | Yes (true) | AuditCommitteeInd |
| Federal Grant Audit Required | false | FederalGrantAuditRequiredInd |
Schedule A IRS990ScheduleA
| Field | Value | IRS element (for citing) |
|---|---|---|
| Public Organization170 | Yes (X) | PublicOrganization170Ind |
Gifts Grants Contri Rcvd170 GiftsGrantsContriRcvd170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $196,010,663 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $210,068,935 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $198,918,214 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $196,804,267 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $199,896,852 | CurrentTaxYearAmt |
| Total | $1,001,698,931 | TotalAmt |
Tax Rev Levied Orgnztnl Bnft170 TaxRevLeviedOrgnztnlBnft170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Govt Furn Srvc Fclts Vl170 GovtFurnSrvcFcltsVl170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total | $0 | TotalAmt |
Total Calendar Year170 TotalCalendarYear170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $196,010,663 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $210,068,935 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $198,918,214 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $196,804,267 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $199,896,852 | CurrentTaxYearAmt |
| Total | $1,001,698,931 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Substantial Contributors Tot | $5,476,665 | SubstantialContributorsTotAmt |
| Public Support Total170 | $996,222,266 | PublicSupportTotal170Amt |
Gross Investment Income170 GrossInvestmentIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $2,015,080 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $1,646,615 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $987,577 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $465,379 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $548,825 | CurrentTaxYearAmt |
| Total | $5,663,476 | TotalAmt |
Unrelated Business Net Incm170 UnrelatedBusinessNetIncm170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $29,449 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $6,810 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $2,516 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $112,437 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $33,150 | CurrentTaxYearAmt |
| Total | $184,362 | TotalAmt |
Other Income170 OtherIncome170Grp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Current Tax Year Minus4 Years | $74,636 | CurrentTaxYearMinus4YearsAmt |
| Current Tax Year Minus3 Years | $136,667 | CurrentTaxYearMinus3YearsAmt |
| Current Tax Year Minus2 Years | $256,146 | CurrentTaxYearMinus2YearsAmt |
| Current Tax Year Minus1 Year | $94,769 | CurrentTaxYearMinus1YearAmt |
| Current Tax Year | $283,014 | CurrentTaxYearAmt |
| Total | $845,232 | TotalAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Support | $1,008,392,001 | TotalSupportAmt |
| Public Support CY170 | 0.98793 | PublicSupportCY170Pct |
| Public Support PY170 | 0.98424 | PublicSupportPY170Pct |
| Thirty Thr Pct Suprt Tests CY170 | Yes (X) | ThirtyThrPctSuprtTestsCY170Ind |
Schedule C IRS990ScheduleC
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Grassroots Lobbying | TotalGrassrootsLobbyingGrp | |
| Total Direct Lobbying | TotalDirectLobbyingGrp | |
| Total Lobbying Expend | TotalLobbyingExpendGrp | |
| Other Exempt Purpose Expend | OtherExemptPurposeExpendGrp | |
| Total Exempt Purpose Expend | TotalExemptPurposeExpendGrp | |
| Lobbying Nontaxable Amount | LobbyingNontaxableAmountGrp | |
| Grassroots Nontaxable | GrassrootsNontaxableGrp | |
| Tot Lbbyng Grassroot Mns Non Tx | TotLbbyngGrassrootMnsNonTxGrp | |
| Tot Lbby Expend Mns Lbbyng Non Tx | TotLbbyExpendMnsLbbyngNonTxGrp | |
| Form4720 Filed | false | Form4720FiledInd |
| Volunteers | Yes (true) | VolunteersInd |
| Paid Staff Or Management | Yes (true) | PaidStaffOrManagementInd |
| Media Advertisements | false | MediaAdvertisementsInd |
| Mailings Members | Yes (true) | MailingsMembersInd |
| Mailings Members | $73,969 | MailingsMembersAmt |
| Publications Or Broadcast | false | PublicationsOrBroadcastInd |
| Grants Other Organizations | Yes (true) | GrantsOtherOrganizationsInd |
| Grants Other Organizations | $210 | GrantsOtherOrganizationsAmt |
| Direct Contact Legislators | Yes (true) | DirectContactLegislatorsInd |
| Direct Contact Legislators | $509,616 | DirectContactLegislatorsAmt |
| Rallies Demonstrations | Yes (true) | RalliesDemonstrationsInd |
| Rallies Demonstrations | $202,384 | RalliesDemonstrationsAmt |
| Other Activities | false | OtherActivitiesInd |
| Total Lobbying Expenditures | $786,179 | TotalLobbyingExpendituresAmt |
| Not Described Section501c3 | false | NotDescribedSection501c3Ind |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | JDRF LOBBYING ACTIVITIES | FormAndLineReferenceDesc |
| Explanation | FORM 990- SCH-C- GENERAL STATEMENT OF ACTIVITIES JDRF is the leading global organization funding type 1 diabetes (T1D) research. Its strength lies in its exclusive focus and singular influence on the worldwide effort to end T1D. Through research and advocacy, JDRF is accelerating progress on the most promising opportunities to cure, prevent and treat T1D and its complications. JDRF's advocacy includes lobbying activity to ensure Congress continues to invest in critically important medical research and puts in place policies to advance the discovery, development, and delivery of better therapies for T1D. JDRF has been instrumental in securing the renewal of the Special Diabetes Program, which provides $150MM annually for T1D research at the National Institutes of Health. JDRF staff and volunteers communicate with government officials through email, phone calls, and meetings, to educate them on issues and encourage the advancement of legislation. | ExplanationTxt |
Schedule D IRS990ScheduleD
| Field | Value | IRS element (for citing) |
|---|---|---|
| Art Public Exhibition Amounts | ArtPublicExhibitionAmountsGrp | |
| Held Works Art | HeldWorksArtGrp |
CY Endwmt Fund CYEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $7,176,427 | BeginningYearBalanceAmt |
| Investment Earnings Or Losses | $367,446 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $102,000 | OtherExpendituresAmt |
| End Year Balance | $7,441,873 | EndYearBalanceAmt |
CY Minus1 Yr Endwmt Fund CYMinus1YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $7,141,514 | BeginningYearBalanceAmt |
| Investment Earnings Or Losses | $37,913 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $3,000 | OtherExpendituresAmt |
| End Year Balance | $7,176,427 | EndYearBalanceAmt |
CY Minus2 Yr Endwmt Fund CYMinus2YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $7,426,222 | BeginningYearBalanceAmt |
| Investment Earnings Or Losses | $11,292 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $296,000 | OtherExpendituresAmt |
| End Year Balance | $7,141,514 | EndYearBalanceAmt |
CY Minus3 Yr Endwmt Fund CYMinus3YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $6,837,461 | BeginningYearBalanceAmt |
| Investment Earnings Or Losses | $625,761 | InvestmentEarningsOrLossesAmt |
| Other Expenditures | $37,000 | OtherExpendituresAmt |
| End Year Balance | $7,426,222 | EndYearBalanceAmt |
CY Minus4 Yr Endwmt Fund CYMinus4YrEndwmtFundGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Beginning Year Balance | $6,728,240 | BeginningYearBalanceAmt |
| Contributions | $100,000 | ContributionsAmt |
| Investment Earnings Or Losses | $9,221 | InvestmentEarningsOrLossesAmt |
| End Year Balance | $6,837,461 | EndYearBalanceAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Prmnnt Endowment Balance EOY | 0.98640 | PrmnntEndowmentBalanceEOYPct |
| Term Endowment Balance EOY | 0.01360 | TermEndowmentBalanceEOYPct |
| Endowments Held Unrelated Org | false | EndowmentsHeldUnrelatedOrgInd |
| Endowments Held Related Org | false | EndowmentsHeldRelatedOrgInd |
| Land | LandGrp | |
| Buildings | BuildingsGrp |
Leasehold Improvements LeaseholdImprovementsGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $4,722,775 | OtherCostOrOtherBasisAmt |
| Depreciation | $3,278,539 | DepreciationAmt |
| Book Value | $1,444,236 | BookValueAmt |
Equipment EquipmentGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Cost Or Other Basis | $26,514,000 | OtherCostOrOtherBasisAmt |
| Depreciation | $18,238,356 | DepreciationAmt |
| Book Value | $8,275,644 | BookValueAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Other Land Buildings | OtherLandBuildingsGrp | |
| Total Book Value Land Buildings | $9,719,880 | TotalBookValueLandBuildingsAmt |
| Financial Derivatives | FinancialDerivativesGrp | |
| Closely Held Equity Interests | CloselyHeldEquityInterestsGrp |
Other Securities OtherSecuritiesGrp (2 entries)
| DescDesc | Book ValueBookValueAmt | Method ValuationMethodValuationCd |
|---|---|---|
| HEDGE FUNDS | $22,477,058 | F |
| US-NON-PUBLIC INVESTMENT FUNDS | $17,390,568 | F |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Book Value Securities | $39,867,626 | TotalBookValueSecuritiesAmt |
| Federal Income Tax Liability | $0 | FederalIncomeTaxLiabilityAmt |
Other Liabilities Org OtherLiabilitiesOrgGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Desc | SPLIT INTEREST CHRT RMDR TRUST | Desc |
| Amt | $2,661,059 | Amt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Liability | $2,661,059 | TotalLiabilityAmt |
| Footnote Text | Yes (X) | FootnoteTextInd |
| Total Rev Etc Audited Fincl Stmt | $206,810,192 | TotalRevEtcAuditedFinclStmtAmt |
| Net Unrealized Gains Invst | $5,008,765 | NetUnrealizedGainsInvstAmt |
| Revenue Not Reported | $5,008,765 | RevenueNotReportedAmt |
| Revenue Subtotal | $201,801,427 | RevenueSubtotalAmt |
| Investment Expenses Not Incld | $452,370 | InvestmentExpensesNotIncldAmt |
| Revenue Not Reported Fincl Stmt | $452,370 | RevenueNotReportedFinclStmtAmt |
| Total Revenue Per Form990 | $202,253,797 | TotalRevenuePerForm990Amt |
| Tot Expns Etc Audited Fincl Stmt | $193,336,962 | TotExpnsEtcAuditedFinclStmtAmt |
| Expenses Subtotal | $193,336,962 | ExpensesSubtotalAmt |
| Investment Expenses Not Incld2 | $452,370 | InvestmentExpensesNotIncld2Amt |
| Expenses Not Rpt Fincl Stmt | $452,370 | ExpensesNotRptFinclStmtAmt |
| Total Expenses Per Form990 | $193,789,332 | TotalExpensesPerForm990Amt |
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| ORGANIZATION'S ENDOWMENT FUNDS | FORM 990, PART X, LINE 28 & 29 & SCH D, PART V THE ORGANIZATION UTILIZES EARNINGS ON ENDOWMENT FUNDS IN THE MANNER SPECIFIED BY THE DONOR AND/OR FOR SUPPORTING THE ORGANIZATIONS GENERAL EXEMPT PURPOSE. |
| INCOME TAX POSITION OF JDRF INT. | 990 SCH-D, PART X, LINE 2 JDRF IS A NOT FOR PROFIT ORGANIZATION EXEMPT FROM FEDERAL INCOME TAXES UNDER SECTION 501 (C) (3) OF THE INTERNAL REVENUE CODE AND IS ORGANIZED UNDER THE LAWS OF THE COMMONWEALTH OF PENNSYLVANIA. INCOME GENERATED FROM ACTIVITIES UNRELATED TO JDRFS EXEMPT PURPOSE IS SUBJECT TO TAX UNDER INTERNAL REVENUE CODE SECTION 511. INCOME TAX LIABILITIES ARE RECOGNIZED WHEN SUCH POSITIONS ARE QUANTIFIABLE AND LIKELY TO BE REALIZED. UNRELATED BUSINESS INCOME TAX LIABILITY WAS INSIGNIFICANT FOR THE YEARS ENDING JUNE 30, 2017 AND 2016. |
Schedule F IRS990ScheduleF
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (true) | GrantRecordsMaintainedInd |
Account Activities Outside US AccountActivitiesOutsideUSGrp (6 entries)
| RegionRegionTxt | Type Of Activities ConductedTypeOfActivitiesConductedTxt | Specific Services ProvidedSpecificServicesProvidedTxt | Region Total ExpendituresRegionTotalExpendituresAmt | OfficesOfficesCnt | EmployeeEmployeeCnt |
|---|---|---|---|---|---|
| North America | Grantmaking | RESEARCH GRANTS | $4,305,000 | ||
| Central America and the Caribbean | Investments | INVESTMENTS | $8,461,823 | ||
| Europe (Including Iceland and Greenland) | Program Services | RESEARCH SUPPORT | $375,453 | 2 | 2 |
| East Asia and the Pacific | Grantmaking | RESEARCH GRANTS | $3,734,400 | ||
| Middle East and North Africa | Grantmaking | RESEARCH GRANTS | $1,472,215 | ||
| Europe (Including Iceland and Greenland) | Grantmaking | RESEARCH GRANTS | $13,479,221 |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Subtotal Offices | 2 | SubtotalOfficesCnt |
| Subtotal Employees | 2 | SubtotalEmployeesCnt |
| Total Office | 2 | TotalOfficeCnt |
| Total Employee | 2 | TotalEmployeeCnt |
| Subtotal Spent | $31,828,112 | SubtotalSpentAmt |
| Total Spent | $31,828,112 | TotalSpentAmt |
Grants To Org Outside US GrantsToOrgOutsideUSGrp (65 entries)
| RegionRegionTxt | Purpose Of GrantPurposeOfGrantTxt | Cash GrantCashGrantAmt | Manner Of Cash DisbursementMannerOfCashDisbursementTxt | Description Of Non Cash AsstDescriptionOfNonCashAsstTxt | Valuation Method UsedValuationMethodUsedDesc |
|---|---|---|---|---|---|
| Europe (Including Iceland and Greenland) | IMMUNE THERAPIES | $50,000 | CHECK/WIRE | N/A | N/A |
| North America | $61,847 | CHECK/WIRE | N/A | N/A | |
| Middle East and North Africa | $770,360 | CHECK/WIRE | N/A | N/A | |
| Europe (Including Iceland and Greenland) | $777,248 | CHECK/WIRE | N/A | N/A | |
| Middle East and North Africa | $250,748 | CHECK/WIRE | N/A | N/A | |
| Europe (Including Iceland and Greenland) | $907,009 | CHECK/WIRE | N/A | N/A | |
| East Asia and the Pacific | $197,513 | CHECK/WIRE | N/A | N/A | |
| East Asia and the Pacific | $468,226 | CHECK/WIRE | N/A | N/A | |
| North America | IMMUNE THERAPIES | $483,604 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | $63,388 | CHECK/WIRE | N/A | N/A | |
| East Asia and the Pacific | $145,000 | CHECK/WIRE | N/A | N/A | |
| North America | $488,106 | CHECK/WIRE | N/A | N/A | |
| North America | $923,269 | CHECK/WIRE | N/A | N/A | |
| Europe (Including Iceland and Greenland) | IMMUNE THERAPIES | $508,049 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | IMMUNE THERAPIES | $441,922 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | $249,673 | CHECK/WIRE | N/A | N/A | |
| North America | $436,051 | CHECK/WIRE | N/A | N/A | |
| Europe (Including Iceland and Greenland) | $931,478 | CHECK/WIRE | N/A | N/A | |
| Europe (Including Iceland and Greenland) | $248,798 | CHECK/WIRE | N/A | N/A | |
| Europe (Including Iceland and Greenland) | IMMUNE THERAPIES | $378,465 | CHECK/WIRE | N/A | N/A |
| East Asia and the Pacific | $333,716 | CHECK/WIRE | N/A | N/A | |
| Europe (Including Iceland and Greenland) | IMMUNE THERAPIES | $110,000 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | IMMUNE THERAPIES | $100,000 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | IMMUNE THERAPIES | $650,000 | CHECK/WIRE | N/A | N/A |
| North America | IMMUNE THERAPIES | $190,250 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | $379,999 | CHECK/WIRE | N/A | N/A | |
| North America | IMMUNE THERAPIES | $1,000,000 | CHECK/WIRE | N/A | N/A |
| East Asia and the Pacific | $1,199,144 | CHECK/WIRE | N/A | N/A | |
| North America | $62,640 | CHECK/WIRE | N/A | N/A | |
| Europe (Including Iceland and Greenland) | IMMUNE THERAPIES | $149,432 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | IMMUNE THERAPIES | $331,590 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | $149,614 | CHECK/WIRE | N/A | N/A | |
| Europe (Including Iceland and Greenland) | $691,243 | CHECK/WIRE | N/A | N/A | |
| Europe (Including Iceland and Greenland) | $169,358 | CHECK/WIRE | N/A | N/A | |
| North America | $92,277 | CHECK/WIRE | N/A | N/A | |
| East Asia and the Pacific | ARTIFICIAL PANCREAS | $250,000 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | $232,580 | CHECK/WIRE | N/A | N/A | |
| Europe (Including Iceland and Greenland) | $2,007,864 | CHECK/WIRE | N/A | N/A | |
| Europe (Including Iceland and Greenland) | IMMUNE THEPAPIES | $440,766 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | $265,937 | CHECK/WIRE | N/A | N/A | |
| Europe (Including Iceland and Greenland) | IMMUNE THERAPIES | $229,626 | CHECK/WIRE | N/A | N/A |
| East Asia and the Pacific | IMMUNE THERAPIES | $150,000 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | $388,107 | CHECK/WIRE | N/A | N/A | |
| Middle East and North Africa | IMMUNE THERAPIES | $451,867 | CHECK/WIRE | N/A | N/A |
| East Asia and the Pacific | $250,000 | CHECK/WIRE | N/A | N/A | |
| North America | IMMUNE THERAPIES | $367,768 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | $681,170 | CHECK/WIRE | N/A | N/A | |
| Europe (Including Iceland and Greenland) | $249,694 | CHECK/WIRE | N/A | N/A | |
| Europe (Including Iceland and Greenland) | BETA CELL | $125,000 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | PREVENTION | $90,787 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | IMMUNE THERAPIES | $262,419 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | BETA CELL | $65,231 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | IMMUNE THERAPIES | $118,496 | CHECK/WIRE | N/A | N/A |
| North America | COMPLICATIONS | $118,639 | CHECK/WIRE | N/A | N/A |
| East Asia and the Pacific | IMMUNE THERAPIES | $499,993 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | IMMUNE THERAPIES | $79,936 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | IMMUNE THERAPIES | $99,532 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | BETA CELL | $125,000 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | REGENERATION | $620,000 | CHECK/WIRE | N/A | N/A |
| East Asia and the Pacific | IMMUNE THERAPIES | $374,920 | CHECK/WIRE | N/A | N/A |
| North America | IMMUNE THERAPIES | $80,550 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | IMMUNE THERAPIES | $232,154 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | IMMUNE THERAPIES | $623,261 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | IMMUNE THERAPIES | $113,157 | CHECK/WIRE | N/A | N/A |
| Europe (Including Iceland and Greenland) | IMMUNE THERAPPIES | $150,000 | CHECK/WIRE | N/A | N/A |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 50 | Total501c3OrgCnt |
| Total Other Org | 15 | TotalOtherOrgCnt |
| Transfer To Foreign Corp | Yes (true) | TransferToForeignCorpInd |
| Interest In Foreign Trust | false | InterestInForeignTrustInd |
| Foreign Corp Ownership | Yes (true) | ForeignCorpOwnershipInd |
| Passive Foreign Investmest Co | Yes (true) | PassiveForeignInvestmestCoInd |
| Foreign Partnership | false | ForeignPartnershipInd |
| Boycott Countries | false | BoycottCountriesInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | GRANT MONITORING PROCEDURES | FormAndLineReferenceDesc |
| Explanation | SCH-F PART I LINE 2 Research grants are awarded by JDRFs Research Committee comprised of "JDRF Board members and other volunteers" following the recommendations of an in-house team of professional scientific staff and with input from external scientific reviewers and patient advocates. The review process includes the following criteria: (1) The scientific merit of the proposed research outlined in a grant application and (2) The relationship of the proposed research to JDRFs goal to cure, prevent and treat T1D and its complications. The scientific research team and grant administration staff maintain close contact with grantees, providing advice, evaluation, research progress reports, helping disseminate research results and reviewing research expenditures versus agreed budgets. | ExplanationTxt |
Schedule G IRS990ScheduleG
| Field | Value | IRS element (for citing) |
|---|---|---|
| Mail Solicitations | Yes (X) | MailSolicitationsInd |
| Email Solicitations | Yes (X) | EmailSolicitationsInd |
| Solicitation Of Non Govt Grants | Yes (X) | SolicitationOfNonGovtGrantsInd |
| Solicitation Of Govt Grants | Yes (X) | SolicitationOfGovtGrantsInd |
| Special Fundraising Events | Yes (X) | SpecialFundraisingEventsInd |
| Agrmt Prof Fundraising Acty | Yes (true) | AgrmtProfFundraisingActyInd |
Fundraiser Activity Info FundraiserActivityInfoGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Person | Insurance Auto Auctions | PersonNm |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | PO Box 2365 | AddressLine1Txt |
| City | Fair Oaks | CityNm |
| State Abbreviation | CA | StateAbbreviationCd |
| ZIP | 95628 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Activity | CAR DONATION | ActivityTxt |
| Fundraiser Control Of Funds | Yes (true) | FundraiserControlOfFundsInd |
| Gross Receipts | $260,800 | GrossReceiptsAmt |
| Retained By Contractor | $95,118 | RetainedByContractorAmt |
| Net To Organization | $165,682 | NetToOrganizationAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total Gross Receipts | $260,800 | TotalGrossReceiptsAmt |
| Total Retained By Contractors | $95,118 | TotalRetainedByContractorsAmt |
| Total Net To Organization | $165,682 | TotalNetToOrganizationAmt |
| Licensed States | AL | LicensedStatesCd |
| Licensed States | AK | LicensedStatesCd |
| Licensed States | AZ | LicensedStatesCd |
| Licensed States | AR | LicensedStatesCd |
| Licensed States | CA | LicensedStatesCd |
| Licensed States | CO | LicensedStatesCd |
| Licensed States | CT | LicensedStatesCd |
| Licensed States | DE | LicensedStatesCd |
| Licensed States | DC | LicensedStatesCd |
| Licensed States | FL | LicensedStatesCd |
| Licensed States | GA | LicensedStatesCd |
| Licensed States | HI | LicensedStatesCd |
| Licensed States | ID | LicensedStatesCd |
| Licensed States | IL | LicensedStatesCd |
| Licensed States | IN | LicensedStatesCd |
| Licensed States | IA | LicensedStatesCd |
| Licensed States | KS | LicensedStatesCd |
| Licensed States | KY | LicensedStatesCd |
| Licensed States | LA | LicensedStatesCd |
| Licensed States | ME | LicensedStatesCd |
| Licensed States | MD | LicensedStatesCd |
| Licensed States | MA | LicensedStatesCd |
| Licensed States | MI | LicensedStatesCd |
| Licensed States | MN | LicensedStatesCd |
| Licensed States | MS | LicensedStatesCd |
| Licensed States | MO | LicensedStatesCd |
| Licensed States | MT | LicensedStatesCd |
| Licensed States | NE | LicensedStatesCd |
| Licensed States | NV | LicensedStatesCd |
| Licensed States | NH | LicensedStatesCd |
| Licensed States | NJ | LicensedStatesCd |
| Licensed States | NM | LicensedStatesCd |
| Licensed States | NY | LicensedStatesCd |
| Licensed States | NC | LicensedStatesCd |
| Licensed States | ND | LicensedStatesCd |
| Licensed States | OH | LicensedStatesCd |
| Licensed States | OK | LicensedStatesCd |
| Licensed States | OR | LicensedStatesCd |
| Licensed States | PA | LicensedStatesCd |
| Licensed States | RI | LicensedStatesCd |
| Licensed States | SC | LicensedStatesCd |
| Licensed States | SD | LicensedStatesCd |
| Licensed States | TN | LicensedStatesCd |
| Licensed States | TX | LicensedStatesCd |
| Licensed States | UT | LicensedStatesCd |
| Licensed States | VT | LicensedStatesCd |
| Licensed States | VA | LicensedStatesCd |
| Licensed States | WA | LicensedStatesCd |
| Licensed States | WV | LicensedStatesCd |
| Licensed States | WI | LicensedStatesCd |
| Licensed States | WY | LicensedStatesCd |
Fundraising Event Information FundraisingEventInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Event1 | SEATTLE GALA | Event1Nm |
| Gross Receipts Event1 | $2,651,726 | GrossReceiptsEvent1Amt |
| Charitable Contri Event1 | $1,970,220 | CharitableContriEvent1Amt |
| Gross Revenue Event1 | $681,506 | GrossRevenueEvent1Amt |
| Non Cash Prizes Event1 | $17,308 | NonCashPrizesEvent1Amt |
| Rent Facility Costs Event1 | $216,426 | RentFacilityCostsEvent1Amt |
| Food And Beverage Event1 | $15,310 | FoodAndBeverageEvent1Amt |
| Entertainment Event1 | $242,509 | EntertainmentEvent1Amt |
| Other Direct Expenses Event1 | $64,290 | OtherDirectExpensesEvent1Amt |
| Event2 | ILLINOIS GALA | Event2Nm |
| Gross Receipts Event2 | $4,927,110 | GrossReceiptsEvent2Amt |
| Charitable Contri Event2 | $4,228,565 | CharitableContriEvent2Amt |
| Gross Revenue Event2 | $698,545 | GrossRevenueEvent2Amt |
| Rent Facility Costs Event2 | $40,547 | RentFacilityCostsEvent2Amt |
| Food And Beverage Event2 | $230,419 | FoodAndBeverageEvent2Amt |
| Entertainment Event2 | $318,066 | EntertainmentEvent2Amt |
| Other Direct Expenses Event2 | $9,364 | OtherDirectExpensesEvent2Amt |
| Other Events Total | 375 | OtherEventsTotalCnt |
| Gross Receipts Other Events | $147,245,819 | GrossReceiptsOtherEventsAmt |
| Charitable Contri Other Events | $121,472,897 | CharitableContriOtherEventsAmt |
| Gross Revenue Other Events | $25,772,922 | GrossRevenueOtherEventsAmt |
| Non Cash Prizes Other Events | $79,306 | NonCashPrizesOtherEventsAmt |
| Rent Fclty Costs Other Events | $3,435,039 | RentFcltyCostsOtherEventsAmt |
| Food And Beverage Other Events | $2,529,307 | FoodAndBeverageOtherEventsAmt |
| Entertainment Other Events | $3,373,875 | EntertainmentOtherEventsAmt |
| Oth Direct Expnss Other Events | $16,581,207 | OthDirectExpnssOtherEventsAmt |
| Gross Receipts Total | $154,824,655 | GrossReceiptsTotalAmt |
| Charitable Contributions Tot | $127,671,682 | CharitableContributionsTotAmt |
| Gross Revenue Total Events | $27,152,973 | GrossRevenueTotalEventsAmt |
| Non Cash Prizes Total Events | $96,614 | NonCashPrizesTotalEventsAmt |
| Rent Fclty Costs Total Events | $3,692,012 | RentFcltyCostsTotalEventsAmt |
| Food And Beverage Total Events | $2,775,036 | FoodAndBeverageTotalEventsAmt |
| Entertainment Total Events | $3,934,450 | EntertainmentTotalEventsAmt |
| Oth Direct Expnss Total Events | $16,654,861 | OthDirectExpnssTotalEventsAmt |
| Direct Expense Summary Events | $27,152,973 | DirectExpenseSummaryEventsAmt |
Gaming Information GamingInformationGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Gross Revenue Other Gaming | $1,106,452 | GrossRevenueOtherGamingAmt |
| Cash Prizes Other Gaming | $10,000 | CashPrizesOtherGamingAmt |
| Non Cash Prizes Other Gaming | $249,790 | NonCashPrizesOtherGamingAmt |
| Volunteer Labor Other Gaming | false | VolunteerLaborOtherGamingInd |
| Gross Revenue Total Gaming | $1,106,452 | GrossRevenueTotalGamingAmt |
| Cash Prizes Total Gaming | $10,000 | CashPrizesTotalGamingAmt |
| Non Cash Prizes Total Gaming | $249,790 | NonCashPrizesTotalGamingAmt |
| Direct Expense Summary Gaming | $259,790 | DirectExpenseSummaryGamingAmt |
| Net Gaming Income Summary | $846,662 | NetGamingIncomeSummaryAmt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| States Where Gaming Conducted | AL | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | AK | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | AZ | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | AR | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | CA | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | CO | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | CT | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | DE | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | DC | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | FL | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | GA | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | HI | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | ID | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | IL | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | IN | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | IA | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | KS | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | KY | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | LA | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | ME | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | MD | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | MA | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | MI | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | MN | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | MS | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | MO | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | MT | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | NE | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | NV | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | NH | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | NJ | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | NM | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | NY | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | NC | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | ND | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | OH | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | OK | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | OR | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | PA | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | RI | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | SC | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | SD | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | TN | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | TX | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | UT | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | VT | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | VA | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | WA | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | WV | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | WI | StatesWhereGamingConductedCd |
| States Where Gaming Conducted | WY | StatesWhereGamingConductedCd |
| Licensed | Yes (true) | LicensedInd |
| License Suspended Etc | false | LicenseSuspendedEtcInd |
| Gaming With Nonmembers | false | GamingWithNonmembersInd |
| Member Of Other Entity | false | MemberOfOtherEntityInd |
| Gaming Other Facility | 1.00000 | GamingOtherFacilityPct |
| Individual With Books | GARY CURTO | IndividualWithBooksNm |
Persons With Books US Address PersonsWithBooksUSAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | 26 BROADWAY-14TH FLOOR | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 10004 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Cntrct With3rd Prty For Game Rev | false | CntrctWith3rdPrtyForGameRevInd |
| Gaming Manager Person | GARY CURTO TAX MANAGER -JDRF | GamingManagerPersonNm |
| Gaming Manager Compensation | $0 | GamingManagerCompensationAmt |
| Gaming Manager Services Prov | FILING GAMING APPLICATIONS AND REPORTS | GamingManagerServicesProvTxt |
| Gaming Manager Is Employee | Yes (X) | GamingManagerIsEmployeeInd |
| Charitable Distribution Rqr | Yes (true) | CharitableDistributionRqrInd |
| Distributed | $846,662 | DistributedAmt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | SCHEDULE G, PART I, LINE 2 | FormAndLineReferenceDesc |
| Explanation | INSURANCE AUTO AUCTIONS LLC IS A STATE LICENSED PROFESSIONAL FUNDRAISER THAT HANDLES ALL ASPECTS OF CARS BEING DONATED TO JDRF. DONORS CONTACT THE COMPANY DIRECTLY THROUGH A TOLL FREE NUMBER TO COORDINATE THE DONATION, FOLLOWING WHICH INSURANCE AUTO AUCTIONS HANDLES ALL REQUIRED IRS 1098C REPORTING. FOR THE PERIOD ENDING 6/30/17, THE CAR PROGRAM RAISED $260,800 WITH TOTAL EXPENSES OF $95,118 WITH THE NET PROCEEDS OF $165,682 PROVIDED DIRECTLY TO JDRF. JDRF PAYS NO ADDITIONAL EXPENSES OR FEES TO INSURANCE AUTO AUCTIONS FOR THIS PROGRAM. | ExplanationTxt |
Schedule I IRS990ScheduleI
| Field | Value | IRS element (for citing) |
|---|---|---|
| Grant Records Maintained | Yes (true) | GrantRecordsMaintainedInd |
Recipient Table RecipientTable (84 entries)
| Address Line1USAddress/AddressLine1Txt | CityUSAddress/CityNm | State AbbreviationUSAddress/StateAbbreviationCd | ZIPUSAddress/ZIPCd | Recipient EINRecipientEIN | IRC SectionIRCSectionDesc | Cash GrantCashGrantAmt | Valuation Method UsedValuationMethodUsedDesc | Non Cash AssistanceNonCashAssistanceDesc | Purpose Of GrantPurposeOfGrantTxt |
|---|---|---|---|---|---|---|---|---|---|
| BENAROYA RESEARCH INST AT VIRGINIA MASON | |||||||||
| 1201 9TH AVE | SEATTLE | WA | 98101 | 910653422 | 501(C)3 | $2,691,474 | N/A | N/A | |
| BD TECHNOLOGIES | |||||||||
| DAVIS DRIVE | RESEARCH TRIANGLE PK | NC | 27709 | 999999999 | $400,000 | N/A | N/A | ||
| ANN AND ROBERT LURIE CHILDREN'S HOSPITAL | |||||||||
| 320 NORTH AVE | PITTSBURGH | PA | 15212 | 362170833 | 501(C)3 | $10,000 | N/A | N/A | |
| CAPILLARY BIOMEDICAL | |||||||||
| 56 HAVENWOOD | IRVINE | CA | 92614 | 464787731 | $130,000 | N/A | N/A | IMMUNE THERAPIES | |
| CASE WESTERN UNIVERSITY | |||||||||
| 10900 EUCLID AVE | CLEVELAND | OH | 44106 | 341018992 | 501(C)3 | $170,816 | N/A | N/A | IMMUNE THERAPIES |
| UNIVERSITY OF ARIZONA | |||||||||
| PO BOX 210 | TUCSON | AZ | 85721 | 113661893 | 501(C)3 | $649,113 | N/A | N/A | |
| CHILDREN'S HOSPITAL OF PHILADELPHIA | |||||||||
| 3401 CIVIC CENTER BLVD | PHIL | PA | 19014 | 231352166 | 501(C)3 | $108,555 | N/A | N/A | IMMUNE THERAPIES |
| CRITICAL PATH INSTITUTE | |||||||||
| 1730 EAST RIVER ROAD | TUCSON | AZ | 85718 | 201991334 | $124,000 | N/A | N/A | ||
| INDIANA UNIVERSITY | |||||||||
| 620 UNION DR | INDIANAPOLIS | IN | 46202 | 356018940 | 501(C)3 | $1,072,836 | N/A | N/A | |
| BETH ISRAEL MEDICAL CENTER | |||||||||
| 1 BROOKLINE AVE | BOSTON | MA | 92121 | 135564934 | 501(C)3 | $506,572 | N/A | N/A | |
| JOSLIN DIABETES CENTER | |||||||||
| 1 JOSLIN PL | BOSTON | MA | 02215 | 042203836 | 501(C)3 | $1,109,271 | N/A | N/A | |
| MASSACHUSETTS INSTITUTE OF TECHNOLOGY | |||||||||
| 25 AMES ST | CAMBRIDGE | MA | 02467 | 042103594 | 501(C)3 | $815,502 | N/A | N/A | |
| INDIANA BIOSCIENCES RES INST | |||||||||
| 1345 W 16TH STREET | INDIANAPOLIS | IN | 46202 | 462882271 | 501(C)3 | $150,000 | N/A | N/A | |
| CALIFORNIA INST FOR BIOMEDICAL RESEARCH | |||||||||
| 11119 NTORRY PINES RD | LAJOLLA | CA | 92037 | 956047739 | 501(C)3 | $2,851,029 | N/A | N/A | |
| EMORY UNIVERSITY | |||||||||
| 69 JESSE HILL JR DRIVE | ATLANTA | GA | 30322 | 580566256 | 501(C)3 | $490,526 | N/A | N/A | |
| MAYO CLINIC | |||||||||
| 1216 2ND STREET | ROCHESTER | MN | 55902 | 411405254 | 501(C)3 | $326,202 | N/A | N/A | IMMUNE THERAPIES |
| GEORGIA TECH RESEARCH CORP | |||||||||
| 505 TENTH STREET | ATLANTA | GA | 30332 | 580603146 | 501(C)3 | $180,695 | N/A | N/A | IMMUNE THERAPIES |
| STANFORD UNIVERSITY | |||||||||
| 300 PASTEUR DR | PALA ALTO | CA | 94305 | 941156365 | 501(C)3 | $772,523 | N/A | N/A | |
| JOHNS HOPKINS UNIVERSITY | |||||||||
| 733 N BROADWAY | BALTIMORE | MD | 21205 | 520595110 | 501(C)3 | $499,991 | N/A | N/A | IMMUNE THERAPIES |
| NEW YORK UNIVERSITY SCHOOL OF MEDICINE | |||||||||
| 550 FIRST AVENUE | NEW YORK | NY | 10016 | 135562309 | 501(C)3 | $510,000 | N/A | N/A | |
| NATIONAL JEWISH HEALTH | |||||||||
| 601 EAST 18TH STREET | DENVER | CO | 80206 | 742044647 | 501(C)3 | $250,000 | N/A | N/A | |
| NORTH CAROLINA STATE UNIVERSITY | |||||||||
| 2701 SULLIVAN DRIVE | RALEIGH | NC | 27695 | 440680117 | 501(C)3 | $540,000 | N/A | N/A | |
| NEW YORK STEM CELL FOUNDATION | |||||||||
| 619 WEST 54TH STREET | NEW YORK | NY | 10019 | 202905531 | 501(C)3 | $200,000 | N/A | N/A | |
| BECKMAN RESEARCH INST OF THE CITY OF HOPE | |||||||||
| 1500 EAST DUARTE ROAD | DUARTE | CA | 91010 | 953432210 | 501(C)3 | $1,171,777 | N/A | N/A | |
| OREGON HEALTH & SCIENCE UNIVERSITY | |||||||||
| 3181 SW SAM JACKSON | PORTLAND | OR | 97239 | 237083114 | 501(C)3 | $464,937 | N/A | N/A | IMMUNE THERAPIES |
| LEXICON PHARMACEUTICALS | |||||||||
| 8800 TECH FOREST PL | THE WOODLANDS | TX | 77381 | 760474179 | $400,000 | N/A | N/A | ||
| PACIFIC DIABETES TECHNOLOGIES | |||||||||
| 12154 SW GARDEN PLACE | PORTLAND | OR | 97223 | 999999999 | 501(C)3 | $178,788 | N/A | N/A | |
| UNIVERSITY OF FLORIDA | |||||||||
| 1600 SW ARCHER ROAD | GAINESVILLE | FL | 32610 | 590974739 | 501(C)3 | $3,291,730 | N/A | N/A | |
| UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL | |||||||||
| 55 LAKE AVE NORTH | WORCESTER | MA | 01605 | 043167352 | 501(C)3 | $70,815 | N/A | N/A | |
| UNIVERSITY OF MIAMI SCHOOL OF MEDICINE | |||||||||
| 1450 NW 10TH AVE | MIAMI | FL | 33136 | 590624458 | 501(C)3 | $1,967,148 | N/A | N/A | |
| UNIVERSITY OF VIRGINIA | |||||||||
| 104 MIDMONT LN | CHARLOTTESVILLE | VA | 22902 | 416042488 | 501(C)3 | $334,651 | N/A | N/A | |
| UNIVERSITY OF MICHIGAN | |||||||||
| 1331 EAST ANN STREET | ANN ARBOR | MI | 48109 | 386006309 | 501(C)3 | $894,233 | N/A | N/A | |
| PACIFIC NORTHWEST RESEARCH INSTITUTE | |||||||||
| 720 BROADWAY | SEATTLE | WA | 98122 | 910667886 | 501(C)3 | $40,233 | N/A | N/A | IMMUNE THERAPIES |
| TETRAGENETICS | |||||||||
| 91 MYSTIC STREET | ARLINGTON | MA | 02474 | 043784099 | $710,000 | N/A | N/A | IMMUNE THERAPIES | |
| UNIVERSITY OF CALIFORNIA | |||||||||
| 3333 CA ST | SAN FRANCISCO | CA | 94122 | 956006143 | 501(C)3 | $5,968,555 | N/A | N/A | |
| UNIVERSITY OF WISCONSIN-MADISON | |||||||||
| 21 NORTH PARK | MADISON | WI | 53706 | 396006492 | 501(C)3 | $650,000 | N/A | N/A | |
| UT SOUTHWESTERN MEDICAL CENTER | |||||||||
| 5323 HARRY HINES BLVD | DALLAS | TX | 75390 | 756002868 | 501(C)3 | $738,690 | N/A | N/A | |
| VANDERBILT UNIVERSITY MEDICAL CENTER | |||||||||
| 1211 MEDICAL CENTER DR | NASHVILLE | TN | 37232 | 620476822 | 501(C)3 | $388,079 | N/A | N/A | |
| BAYLOR COLLEGE OF MEDICINE-RESEARCH INSTITUTE | |||||||||
| 3500 GASTON AVE | DALLAS | TX | 75246 | 751921898 | 501(C)3 | $246,356 | N/A | N/A | |
| BROAD INSTITUTE | |||||||||
| 7 CAMBRIDGE CENTER | CAMBRIDGE | MA | 02142 | 263428781 | 501(C)3 | $285,342 | N/A | N/A | |
| DUKE UNIVERSITY | |||||||||
| 4321 MEDICAL PARK DR | DURHAM | NC | 27704 | 560532129 | 501(C)3 | $368,992 | N/A | N/A | |
| UNIVERSITY OF CONNECTICUT | |||||||||
| 69 N EAGLEVILLE | STORRS | CT | 06269 | 066085975 | 501(C)3 | $249,999 | N/A | N/A | IMMUNE THERAPIES |
| UNIVERSITY OF SOUTH FLORIDA | |||||||||
| 4202 E FOWLER AVE | TAMPA | FL | 33620 | 590879015 | 501(C)3 | $423,532 | N/A | N/A | IMMUNE THERAPIES |
| JAEB CENTER FOR HEALTH RESEARCH FND | |||||||||
| 15310 Amberly Drive | TAMPA | FL | 33647 | 593187624 | 501(C)3 | $3,950,383 | N/A | N/A | |
| VIACYTE | |||||||||
| 3550 GENERAL ATOMICS | SAN DIEGO | CA | 92121 | 330884172 | $2,000,000 | N/A | N/A | ||
| COLUMBIA UNIVERSITY | |||||||||
| PO BOX 29789 | NEW YORK | NY | 10087 | 135598093 | 501(C)3 | $327,912 | N/A | N/A | |
| YALE UNIVERSITY | |||||||||
| PO BOX 209010 | NEW HAVEN | CT | 06520 | 060646973 | 501(C)3 | $861,255 | N/A | N/A | IMMUNE THERAPIES |
| UNIVERSITY OF ALABAMA | |||||||||
| COLLEGE DRIVE | BIRMINGHAM | AL | 35294 | 636001138 | 501(C)3 | $627,092 | N/A | N/A | |
| NORTHWESTERN UNIVERSITY | |||||||||
| 633 CLARK STREET | EVANSTON | IL | 60208 | 231352685 | 501(C)3 | $922,961 | N/A | N/A | |
| DANA-FARBER CANCER INSTITUTE | |||||||||
| 450 BROOKLINE AVE | BOSTON | MA | 02115 | 042263040 | 501(C)3 | $60,816 | N/A | N/A | BETA CELL THERAPIES |
| SELECTA BIOSCIENCE INC | |||||||||
| 480 ARSENAL STREET | WATERTOWN | MA | 02472 | 261622110 | $47,879 | N/A | N/A | ||
| THE UNIVERSITY OF CHICAGO | |||||||||
| 5801 SOUTH ELLIS AVE | CHICAGO | IL | 60637 | 362177139 | 501(C)3 | $249,998 | N/A | N/A | |
| ICAHN SCHOOL OF MEDICINE MOUNT SINAI | |||||||||
| 1 GUSTAVE L LEVY PLACE | NEW YORK | NY | 10029 | 136171197 | 501(C)3 | $637,698 | N/A | N/A | |
| NOVARTIS INSTITUTE-GENOMICS | |||||||||
| 10675 JOHN HOPKINS DR | SAN DIEGO | CA | 92121 | 223610512 | $504,565 | N/A | N/A | ||
| ILLINOIS INSTITUTE OF TECHNOLOGY | |||||||||
| 3300 SOUTH FEDERAL STREET | CHICAGO | IL | 60616 | 362170136 | 501(C)3 | $246,082 | N/A | N/A | |
| UNIVERSITY OF MINNESOTA | |||||||||
| 80 SOUTH 8TH STREET | MINNEAPOLIS | MN | 55455 | 416007513 | 501(C)3 | $1,149,643 | N/A | N/A | |
| JACKSON LABORATORY | |||||||||
| 600 MAIN STREET | BAR HARBOR | ME | 04609 | 010211513 | 501(C)3 | $62,640 | N/A | N/A | |
| RUTGERS THE STATE UNIVERSITY | |||||||||
| 175 UNIVERSITY AVE | NEWARK | NJ | 07107 | 462354111 | 501(C)3 | $347,735 | N/A | N/A | IMMUNE THERAPIES |
| UNIVERSITY OF WASHINGTON | |||||||||
| 1401 15TH AVE | SEATTLE | WA | 98195 | 911486484 | 501(C)3 | $543,444 | N/A | N/A | |
| WESTERN MICHIGAN UNIVERSITY | |||||||||
| 1903 W MICHIGAN ANE | KALAMAZOO | MI | 49008 | 454135256 | 501(C)3 | $127,088 | N/A | N/A | |
| CLEMSON UNIVERSITY | |||||||||
| 105 COLLINGS ST | CLEMSON | SC | 29634 | 157600025 | 501(C)3 | $10,000 | N/A | N/A | PREVENTION |
| DIABETOMICS | |||||||||
| 2345 AMBERBROOK | HILLSBORO | OR | 97006 | 273132477 | $90,000 | N/A | N/A | PREVENTION | |
| OHIO STATE UNIVERSITY | |||||||||
| 281 W Lane AVE | COLUMBUS | OH | 43210 | 611730890 | 501(C)3 | $140,000 | N/A | N/A | ARTIFICIAL PANCREAS |
| THE BRIGHAM AND WOMEN'S HOSPITAL | |||||||||
| 75 FRANCIS STREET | BOSTON | MA | 02115 | 042312909 | 501(C)3 | $164,996 | N/A | N/A | COMPLICATIONS |
| THOMAS JEFFERSON UNIVERSITY | |||||||||
| 125 S 9TH STREET | PHILADELPHIA | PA | 19019 | 232829095 | 501(C)3 | $110,000 | N/A | N/A | ARTIFICIAL PANCREAS |
| TIDEPOOL | |||||||||
| 450 TOWNSEND ST | SAN FRANCISCO | CA | 94107 | 462302287 | $2,076,155 | N/A | N/A | ARTIFICIAL PANCREAS | |
| WAVE 80 BIOSCIENCES | |||||||||
| 2325 THIRD STREET | SAN FRANCISCO | CA | 94107 | 020691818 | $80,000 | N/A | N/A | PREVENTION | |
| UNIVERSITY OF UTAH | |||||||||
| 201 PRESIDENTS CR | SALT LAKE CITY | UT | 84102 | 876000525 | 501(C)3 | $858,631 | N/A | N/A | GLUCOSE MODULATION |
| WAYNE STATE UNIVERSITY | |||||||||
| 5700 CASS AVE | DETROIT | MI | 48201 | 383555142 | 501(C)3 | $269,856 | N/A | N/A | ENCAPSULATED ISLETS |
| ALLEGHENY SINGER RESEARCH INST | |||||||||
| 320 E NORTH AVENUE | PITTSBURGH | PA | 15212 | 251320493 | $249,999 | N/A | N/A | BETA CELL THERAPIES | |
| HARVARD MEDICAL SCHOOL | |||||||||
| 200 LONGWOOD AVE | BOSTON | MA | 02115 | 042103580 | 501(C)3 | $883,862 | N/A | N/A | IMMUNE THERAPIES |
| PRODO LABORATORIES | |||||||||
| 27402 ALISO VIEJO PKY | ALISO VIEJO | CA | 92656 | 205534494 | $36,478 | N/A | N/A | IMMUNE THERAPIES | |
| PROTOMER TECHNOLOGIES | |||||||||
| 430 S CATALINA AVE | PASADENA | CA | 91106 | 474206994 | $280,000 | N/A | N/A | IMMUNE THERAPIES | |
| UNIVERSITY OF SOUTHERN CALIFORNIA | |||||||||
| COLLEGE DRIVE | LOS ANGELES | CA | 90089 | 951642394 | 501(C)3 | $362,454 | N/A | N/A | IMMUNE THERAPIES |
| UNIVERSITY OF COLORADO | |||||||||
| PO BOX 6511 | DENVER | CO | 80045 | 846049811 | 501(C)3 | $1,490,772 | N/A | N/A | IMMUNE THERAPIES |
| UNIVERSITY OF ILLINOIS | |||||||||
| 1200 HARRISON | CHICAGO | IL | 60612 | 376006007 | 501(C)3 | $236,202 | N/A | N/A | IMMUNE THERAPIES |
| UNITIO | |||||||||
| 11 AVENUE DE LAYFETTE | BOSTON | MA | 02111 | 451623549 | $491,763 | N/A | N/A | IMMUNE THERAPIES | |
| UNIVERSITY OF MARYLAND | |||||||||
| COLLEGE PAR ROAD | COLLEGE PARK | MD | 20737 | 522004514 | 501(C)3 | $524,761 | N/A | N/A | IMMUNE THERAPIES |
| UNIVERSITY OF NEBRASKA | |||||||||
| 151 WHITTIER | LINCOLN | NE | 68503 | 470379839 | 501(C)3 | $247,021 | N/A | N/A | IMMUNE THERAPIES |
| UNIVERSITY OF TEXAS HEALTH SCIENCE | |||||||||
| 7703 FLOYD CURL DRIVE | SAN ANTONIO | TX | 78229 | 741586031 | 501(C)3 | $95,000 | N/A | N/A | IMMUNE THERAPIES |
| WASHINGTON UNIVERSITY | |||||||||
| One Brookings Drive | St Louis | MO | 63130 | 430653611 | 501(C)3 | $708,716 | N/A | N/A | IMMUNE THERAPIES |
| UNIVERSITY OF KANSAS CENTER FOR RESEARCH | |||||||||
| 1200 SUNNYSIDE AVE | LAWRENCE | KS | 66045 | 480680117 | 501(C)3 | $249,997 | N/A | N/A | IMMUNE THERAPIES |
| AUGUSTA UNIVERSITY RESEARCH INSTITUTE | |||||||||
| 1474 LANEY WALKER BLVD | AUGUSTA | GA | 30912 | 581418202 | 501(C)3 | $110,889 | N/A | N/A | |
| BOSTON HEALTH ECONOMICS INC | |||||||||
| 222 BERKLEY STREET | BOSTON | MA | 02116 | 043311183 | $242,020 | N/A | N/A | ||
| Field | Value | IRS element (for citing) |
|---|---|---|
| Total501c3 Org | 68 | Total501c3OrgCnt |
| Total Other Org | 16 | TotalOtherOrgCnt |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | GRANT MONITORING PROCEDURES | FormAndLineReferenceDesc |
| Explanation | SCH-I PART I LINE 2 Research grants are awarded by JDRFs Research Committee comprised of "JDRF Board members and other volunteers" following the recommendations of an in-house team of professional scientific staff and with input from external scientific reviewers and patient advocates. The review process includes the following criteria: (1) The scientific merit of the proposed research outlined in a grant application and (2) The relationship of the proposed research to JDRFs goal to cure, prevent and treat T1D and its complications. The scientific research team and grant administration staff maintain close contact with grantees, providing advice, evaluation, research progress reports, helping disseminate research results and reviewing research expenditures versus agreed budgets. | ExplanationTxt |
Schedule J IRS990ScheduleJ
| Field | Value | IRS element (for citing) |
|---|---|---|
| Housing Allowance Or Residence | Yes (X) | HousingAllowanceOrResidenceInd |
| Written Policy Ref T And E Expnss | Yes (true) | WrittenPolicyRefTAndEExpnssInd |
| Substantiation Required | false | SubstantiationRequiredInd |
| Compensation Committee | Yes (X) | CompensationCommitteeInd |
| Independent Consultant | Yes (X) | IndependentConsultantInd |
| Form990 Of Other Organizations | Yes (X) | Form990OfOtherOrganizationsInd |
| Compensation Survey | Yes (X) | CompensationSurveyInd |
| Board Or Committee Approval | Yes (X) | BoardOrCommitteeApprovalInd |
| Severance Payment | Yes (true) | SeverancePaymentInd |
| Supplemental Nonqual Rtr Plan | false | SupplementalNonqualRtrPlanInd |
| Equity Based Comp Arrngm | false | EquityBasedCompArrngmInd |
| Comp Based On Revenue Of Flng Org | false | CompBasedOnRevenueOfFlngOrgInd |
| Comp Bsd On Rev Related Orgs | false | CompBsdOnRevRelatedOrgsInd |
| Comp Bsd Net Earns Flng Org | false | CompBsdNetEarnsFlngOrgInd |
| Comp Bsd Net Earns Rltd Orgs | false | CompBsdNetEarnsRltdOrgsInd |
| Any Non Fixed Payments | Yes (true) | AnyNonFixedPaymentsInd |
| Initial Contract Exception | false | InitialContractExceptionInd |
Rltd Org Officer Trst Key Empl RltdOrgOfficerTrstKeyEmplGrp (10 entries)
| TitleTitleTxt | Base Compensation Filing OrgBaseCompensationFilingOrgAmt | Compensation Based On Rltd OrgsCompensationBasedOnRltdOrgsAmt | Bonus Related OrganizationsBonusRelatedOrganizationsAmt | Other Compensation Filing OrgOtherCompensationFilingOrgAmt | Other Compensation Rltd OrgsOtherCompensationRltdOrgsAmt | Deferred Compensation Flng OrgDeferredCompensationFlngOrgAmt | Nontaxable Benefits Filing OrgNontaxableBenefitsFilingOrgAmt | Total Compensation Filing OrgTotalCompensationFilingOrgAmt | Total Compensation Rltd OrgsTotalCompensationRltdOrgsAmt | Bonus Filing OrganizationBonusFilingOrganizationAmount | Deferred Comp Rltd OrgsDeferredCompRltdOrgsAmt | Nontaxable Benefits Rltd OrgsNontaxableBenefitsRltdOrgsAmt |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DEREK RAPP | ||||||||||||
| PRESIDENT AND CEO | $582,000 | $0 | $0 | $143,000 | $0 | $12,337 | $36,378 | $773,715 | $0 | |||
| JULIA GREENSTEIN | ||||||||||||
| VP RESEARCH | $264,800 | $0 | $0 | $18,000 | $0 | $12,337 | $2,276 | $297,413 | $0 | |||
| AARON KOWALSKI | ||||||||||||
| CHIEF MISSION OFFICER | $300,000 | $7,912 | $27,749 | $385,661 | $50,000 | |||||||
| SANDRA HIJIKATA | ||||||||||||
| CHIEF DEV OFFICER & ASST. SECY | $356,333 | $12,000 | $12,337 | $5,943 | $386,613 | |||||||
| MARK GREENE | ||||||||||||
| CFO & ASST. TRES | $345,125 | $18,000 | $12,337 | $9,951 | $385,413 | |||||||
| RICHARD INSEL ENDED 63016 | ||||||||||||
| CHIEF SCIENTIFIC OFFICER | $319,352 | $285,750 | $12,337 | $15,008 | $632,447 | |||||||
| JILL CLARK | ||||||||||||
| CHIEF OF STAFF & ASST. SECY | $227,421 | $4,410 | $10,828 | $3,875 | $255,534 | $9,000 | ||||||
| MARGO LUCERO | ||||||||||||
| SVP CORPORATE DEVELOPMENT | $262,640 | $5,360 | $12,337 | $25,936 | $306,273 | |||||||
| STEVEN GRIFFEN MD | ||||||||||||
| SVP RESEARCH | $376,433 | $600 | $12,337 | $30,210 | $419,580 | |||||||
| JONATHAN R BEHR | ||||||||||||
| MANAGING DIRECTOR JDRF-T1D FND | $25,000 | $0 | $0 | $0 | $0 | $0 | $0 | $25,000 | $0 | $0 | $0 | $0 |
Supplemental Information Detail SupplementalInformationDetail (4 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| HOUSING ALLOWANCE | SCHEDULE J PART I, LINE 1A Derek Rapp, Pres & CEO, received a housing allowance as per the terms of his employment agreement. For the 2016 calendar year, the housing allowance provided to Derek Rapp was $75,000; such amount was treated as taxable compensation and included in his Form W-2. This amount was also reported on Schedule J, Part II, Col. (B) (III). Dr. Richard Insel, chief scientific officer, received a housing allowance as per the terms of his employment agreement. For the 2016 calendar year, the housing allowance provided to Dr. Insel was $25,000; such amount was treated as taxable compensation and included in his Form W-2. This amount was also reported on Schedule J,Part II, Col (B) (III). |
| OTHER REPORTABLE COMPENSATION | SCHEDULE J PART II, COL (B)(iii) DEREK RAPP RECEIVED TRAVEL & ALLOWANCE EXPENSES FOR THE 2016 CALENDAR YEAR, THE ALLOWANCE PROVIDED TO MR. RAPP WAS $50,000; SUCH AMOUNT WAS TREATED AS TAXABLE COMPENSATION AND INCLUDED IN HIS FORM W-2. THIS AMOUNT WAS ALSO REPORTED ON SCHEDULE J, PART II, COL (B)(iii). |
| NON-FIXED PAYMENTS | FORM 990, SCHEDULE J, PART I, LINE 7 JDRF AWARDS NON-FIXED PAYMENTS SUCH AS BONUSES ON A DISCRETIONARY BASIS TIED TO THE EMPLOYEES PERFORMANCE. THE NAMES OF EMPLOYEES AND THE AMOUNTS THAT WERE PAID ARE FOUND ON SCHEDULE J, PAGE 2, PART II, COL. (B) (II). |
| SEVERANCE PAYMENTS | SCHEDULE J, PART I, LINE 4A DR. RICHARD INSEL RECEIVED A SEVERANCE PAYMENT OF $252,500 WHICH IS REPORTED ON SCHEDULE J, PART II, COL. (B)(III) OTHER REPORTABLE COMPENSATION. |
Schedule L IRS990ScheduleL
Bus Tr Involve Interested Prsn BusTrInvolveInterestedPrsnGrp (2 entries)
| Relationship DescriptionRelationshipDescriptionTxt | TransactionTransactionAmt | TransactionTransactionDesc | Sharing Of RevenuesSharingOfRevenuesInd |
|---|---|---|---|
| ELIZABETH KECKLER | |||
| DAUGHTER OF ELLEN LEAKE | $86,773 | EMPLOYMENT AT JDRF INT. | false |
| LINDSAY ALTMAN | |||
| DAUGHTER OF LISA ALTMAN | $22,001 | EMPLOYMENT AT JDRF INT. | false |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | BUSINESS TRANSACTION | FormAndLineReferenceDesc |
| Explanation | SCHEDULE L, PART IV, COLUMN B ELLEN LEAKE WAS THE BOARD VICE-CHAIR FOR YEAR END 6/30/2017 LISA ALTMAN WAS A JDRF BOARD MEMBER FOR YEAR END 6/30/2017 SCHEDULE L, PART IV, COLUMN C FOR EMPLOYEES LISTED, TOTAL COMPENSATION INCLUDES EMPLOYER PAID BENEFITS | ExplanationTxt |
Schedule M IRS990ScheduleM
| Field | Value | IRS element (for citing) |
|---|---|---|
| Works Of Art | WorksOfArtGrp | |
| Art Historical Treasures | ArtHistoricalTreasuresGrp | |
| Art Fractional Interest | ArtFractionalInterestGrp | |
| Books And Publications | BooksAndPublicationsGrp | |
| Clothing And Household Goods | ClothingAndHouseholdGoodsGrp |
Cars And Other Vehicles CarsAndOtherVehiclesGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | Yes (X) | NonCashCheckboxInd |
| Contribution | 8 | ContributionCnt |
| Noncash Contributions Rpt F990 | $249,790 | NoncashContributionsRptF990Amt |
| Method Of Determining Revenues | TICKET SALES | MethodOfDeterminingRevenuesTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Boats And Planes | BoatsAndPlanesGrp | |
| Intellectual Property | IntellectualPropertyGrp |
Securities Publicly Traded SecuritiesPubliclyTradedGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | Yes (X) | NonCashCheckboxInd |
| Contribution | 372 | ContributionCnt |
| Noncash Contributions Rpt F990 | $4,994,790 | NoncashContributionsRptF990Amt |
| Method Of Determining Revenues | NET PROCEEDS OF SALE | MethodOfDeterminingRevenuesTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Securities Closely Held Stock | SecuritiesCloselyHeldStockGrp | |
| Secur Prtnrshp Trust Intrsts | SecurPrtnrshpTrustIntrstsGrp | |
| Securities Miscellaneous | SecuritiesMiscellaneousGrp | |
| Qualified Contrib Hist Struct | QualifiedContribHistStructGrp | |
| Qualified Contrib Other | QualifiedContribOtherGrp | |
| Real Estate Residential | RealEstateResidentialGrp | |
| Real Estate Commercial | RealEstateCommercialGrp | |
| Real Estate Other | RealEstateOtherGrp | |
| Collectibles | CollectiblesGrp | |
| Food Inventory | FoodInventoryGrp | |
| Drugs And Medical Supplies | DrugsAndMedicalSuppliesGrp | |
| Taxidermy | TaxidermyGrp | |
| Historical Artifacts | HistoricalArtifactsGrp | |
| Scientific Specimens | ScientificSpecimensGrp | |
| Archaeological Artifacts | ArchaeologicalArtifactsGrp |
Other Non Cash Contri Table OtherNonCashContriTableGrp
| Field | Value | IRS element (for citing) |
|---|---|---|
| Non Cash Checkbox | Yes (X) | NonCashCheckboxInd |
| Desc | MISC AUCTION ITEMS DONATED | Desc |
| Contribution | 27720 | ContributionCnt |
| Noncash Contributions Rpt F990 | $11,979,668 | NoncashContributionsRptF990Amt |
| Method Of Determining Revenues | FAIR MARKET VALUE | MethodOfDeterminingRevenuesTxt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form8283 Received | 1 | Form8283ReceivedCnt |
| Any Property That Must Be Held | false | AnyPropertyThatMustBeHeldInd |
| Review Process Unusual NC Gifts | Yes (true) | ReviewProcessUnusualNCGiftsInd |
| Third Parties Used | Yes (true) | ThirdPartiesUsedInd |
Supplemental Information Detail SupplementalInformationDetail (2 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| THIRD PARTY ASSISTANCE | LINE 32B INSURANCE AUTO AUCTIONS LLC IS A THIRD PARTY CAR DONATION COMPANY THAT HANDLES ALL ASPECTS OF CARS BEING DONATED TO JDRF. DONORS CALL A TOLL FREE NUMBER AND THEY ARE PUT IN CONTACT WITH A TOWING SERVICE IN THEIR AREA. AFTER THE CAR IS DONATED, INSURANCE AUTO AUCTIONS HANDLES ALL IRS 1098-C REPORTING. INSURANCE AUTO AUCTIONS IS A LICENSED PROFESSIONAL FUNDRAISER AND IS LICENSED IN THE STATES THAT REQUIRE IT TO REGISTER. FOR THE PERIOD ENDING 6/30/17, THE CAR PROGRAM LLC RAISED $260,800 WITH TOTAL EXPENSES OF $95,118. A NET CHECK IS PAID DIRECTLY TO JDRF. JDRF DOES NOT PAY INSURANCE AUTO AUCTIONS ANY EXPENSES OR FEES DIRECTLY. TOTAL NET REVENUE FOR FY-17 WAS $165,682. |
| NONCASH CONTRIBUTIONS | FORM 990, SCHEDULE M, PAGE 1 TYPES OF PROPERTY AND THE AMOUNTS LISTED IN PART I LINES 6, 9, and 25 ARE THE ACTUAL AMOUNT THAT DONORS HAVE DONATED FOR VEHICLES, SECURITIES, AND MISC ITEMS THAT ARE SOLD AT VARIOUS AUCTIONS & RAFFLES. |
Schedule O IRS990ScheduleO
Supplemental Information Detail SupplementalInformationDetail (5 entries)
| Form And Line ReferenceFormAndLineReferenceDesc | ExplanationExplanationTxt |
|---|---|
| ORGANIZATION'S MISSION | FORM 990, PART III, LINE 1 JDRFs mission is to accelerate life-changing breakthroughs to cure, prevent and treat Type 1 Diabetes (T1D) and its complications. JDRF is the leading global organization focused on T1D research and is committed to funding the development of new therapies and treatments to keep people with T1D healthier, longer, until a cure is found. Its strength lies in its exclusive focus and singular influence on the worldwide effort to end T1D. JDRF works every day to change the reality of this life-threatening autoimmune disease for millions of people - and to prevent anyone else from contracting the disease - by funding research, advocating for government support of research and new therapies, ensuring new therapies and technologies come to market, and connecting and engaging the T1D community. JDRF has funded more than $2 billion in research to date and made significant progress in understanding and fighting the disease. JDRF has played a role in nearly every T1D therapeutic advance of the past four decades, including the FDA-approved hybrid closed-loop artificial pancreas system in September 2016. PART III: STATEMENT OF PROGRAM SERVICE ACCOMPLISHMENTS LINE 4A ($79,009,656) RESEARCH GRANTS JDRF funds research with the greatest potential to cure, prevent and treat type 1 diabetes (T1D). Its strength lies in its exclusive focus and singular influence on the worldwide effort to end T1D. JDRF has committed more than $2 billion to this research since 1970. The full impact of JDRFs research investment extends well beyond direct funding. JDRF leverages partnerships with academia, industry and clinicians to ensure that the most promising research opportunities are funded and accelerated. JDRF also provides early stage funding to research projects, and the results of those projects often lead to follow-on participation from many other entities, including other non-for-profit funders and corporations. JDRF's research team is staffed by accomplished experts and leaders in the field of T1D science and medicine who guide the organization's funding efforts. JDRFs highest priority remains funding research to deliver a cure for T1D and its complications. At the same time, JDRF is focused on developing better treatments that will transform the way people with T1D treat the disease today to help them live healthier lives now and in the future. The foundation's diversified research portfolio includes the following therapy areas: Artificial Pancreas: Artificial pancreas systems use technology to replicate the operation of a normal human pancreas and are one of the most revolutionary advances in diabetes care since the discovery of insulin. These systems link continuous glucose monitors and insulin pumps to smart software so that the right amount of insulin is delivered at the right time. Glucose Control: Glucose-responsive insulins (GRIs), or smart insulins, promise to be a game-changer in blood-sugar management. GRIs will be the first-ever insulin formulation that turns on and off in response to blood sugar highs and lows. JDRF is also funding research that explores the benefits of combining novel or repurposed drugs with standard insulin therapy. Beta Cell Replacement: This therapy, also known as encapsulation, can be implanted to provide long-term relief from insulin dosing without the need for immune suppression. JDRF-supported scientists are improving biomaterials for encapsulation devices to protect implanted beta cells from autoimmune attack, among other strategies. Beta Cell Restoration: This drug or biologic-based therapy represents a full biological cure for people with T1D. It stimulates restoration of the bodys own beta cells and the capacity to produce insulin. We are repurposing drugs that may reduce beta cell stress and/or induce survival, as well as funding immune therapies that will stop the disease in its tracks. Complications: JDRF-funded research has already yielded new treatments for diabetic eye and kidney disease, the most common complications. Today, researchers are identifying biomarkers and accelerating the completion of clinical trials of potential treatments. Prevention: JDRF research has identified a number of potential triggers, including viruses and environmental conditions, which could open the door to new vaccines and other prevention strategies. The organization is also funding efforts to stall the progression of the disease in those at risk or newly diagnosed. For more information, visit jdrf.org/research. The JDRF T1D Fund (www.t1dfund.org), a wholly owned subsidiary of JDRF, is a venture philanthropy fund accelerating life-changing solutions to treat, prevent and cure T1D through catalytic commercial investments. Through its investments in partnership with private capital, including venture capital, pharma and foundations, the T1D Fund seeks to attract the private investment necessary to advance drugs, devices, diagnostics, and vaccines into the hands of those living with T1D. The T1D Fund invests in whitespace opportunities and areas strategically aligned with JDRF, with an exclusive focus on the best commercial opportunities. All funds were deployed to directly support companies developing approaches to treat, prevent and cure T1D and are aligned with the JDRF mission. In accordance with GAAP, $7.1MM of the T1D Funds total investments for the FY17 period are reflected in the Balance Sheet (Part X) and not included within the organizations research-related mission expense. LINE 4B ($20,866,569) RESEARCH SUPPORT JDRF maintains an in-house team of skilled and credentialed scientific, policy and government relations professionals, each of whom plays a critical role in leading and supporting the research strategy and the disbursement of research funds from JDRF and others to create a world without type 1 diabetes (T1D). In their respective responsibilities, these professionals perform the functions of identifying, evaluating and influencing groundbreaking research being funded by JDRF, other foundations, governments and industry to achieve the organization's mission. These professionals also work with regulatory and policy officials to ensure research can proceed without delay and that research results are well understood by healthcare decision makers. As part of these efforts, JDRF organizes and funds scientific meetings, symposia, and conferences with the purpose of reviewing research proposals, ensuring that JDRF's research strategy is well aligned with the needs of the T1D community and allowing JDRF to provide scientific updates on the research it manages. JDRF also works with its external Research Advisory Committee (RAC), which is composed of professionals who are internationally renowned for their expertise in research as well as the care and treatment of those with T1D. The RAC advises on matters of policy pertaining to research philosophy and procedures to help the organization be most effective. All of this work to convene the best minds in the field enhances JDRF's ability to forecast future scientific direction, to judge the potential efficiency and effectiveness of new pathways and to identify gaps where JDRF can focus its funding to make the most impact. It is from this position of strength that JDRF identified opportunities where the Foundation can make significant advances in the near future and launched a five-year strategic plan in 2015 to accelerate progress to cure, prevent and treat T1D and its complications. LINE 4C ($52,763,561) PUBLIC EDUCATION Because of its leading role in type 1 diabetes (T1D) research globally, JDRF is in a unique position to provide public education about diabetes and its complications. JDRF's efforts impact not only the millions of people with the disease and their families and the general public, but also those at risk for developing the disease. Type 1 diabetes strikes both children and adults suddenly, and the adjustment period following a diagnosis can be overwhelming. JDRF educates people about the warning signs of T1D, which can be profoundly helpful in ensuring timely diagnoses and reducing the potential, short-term, catastrophic consequences of T1D. JDRF also provides information and updates about current research directions and progress and about human clinical trials that are seeking participants (including through JDRF's Clinical Trials Connection matching tool: www.jdrf.org/research/clinical-trials). Through all of its U.S. chapters and online, JDRF supports the T1D communitys diverse needs, connecting people with local support, expert resources and the worldwide effort to end this serious disease. |
| CONFLICT OF INTEREST POLICY | FORM 990- PART VI-SECT B, LINE 12C All officers, directors, key employees, board and committee members (both chapters and international boards) are required to sign a conflict of interest policy annually and disclose any conflicts. The Office of the President and CEO manages this process, and JDRF's internal audit department annually audits to ensure compliance. If any conflict does arise, the board members with the conflicts will recuse themselves from the meeting and/or vote. |
| PUBLIC DOCUMENTS | FORM 990, PAGE 6, PART VI, SECTION C, LINE 19 The organization makes its governing documents, conflict of interest policy and financial statements available to the public on its website: www.JDRF.org. The public may access copies of JDRF's W-9, annual reports, 990 tax returns, 501(c)(3) IRS letter, and audited financials, at the following link: www.jdrf.org/about/financials |
| EXECUTIVE COMPENSATION POLICY | PART VI, SECTION B, LINES 15a & 15b JDRFs Board of Directors charges a Talent and Compensation Committee to develop and recommend a compensation philosophy that applies to all employees of JDRF, including recommendations regarding the compensation and benefits of JDRF senior management for approval by the Executive Committee. The Committee works in collaboration with the President and CEO and the Chief People Officer and other senior staff personnel in the JDRF Human Resources Department to ensure that 1) the Foundations talent strategy supports and is aligned with its overall organization strategies; 2) JDRF is in compliance with IRS guidelines for determining reasonableness in pay practices; and 3) overall compensation for JDRFs key executives is competitive and aligned with pay philosophy. To attract and retain top scientific and executive talent to advance its mission, the organization pays competitive and appropriate salaries as determined by analysis of reliable data and input from independent third-party consultants. The review of JDRF executive compensation and benefits under the procedures noted above is completed annually by an independent Compensation Committee, and the basis for their determination are documented contemporaneously in the minutes of the Committees meetings, including most recently on November 10, 2016. |
| FORM 990 REVIEW PROCESS | SECTION B, PART VI, QUESTION 11B JDRF has a rigorous standard approach to reviewing its 990. The Organization's Tax Manager works with its outside tax professionals to prepare the return and all supporting schedules. The draft return is reviewed by a number of individuals, including JDRFs Chief Financial Officer and Director of Accounting and Finance, the Chief Executive Officer, other executives, its external senior tax advisor and others as necessary to ensure accuracy. Any questions and changes with respect to the draft return are addressed. Following this process, the return is reviewed by JDRFs Audit Committee of the Board of Directors with its outside tax advisors. Once approved, the return is distributed to all members of JDRFs Board of Directors for review and comment before it is filed with the Internal Revenue Service. KEY EMPLOYEE FORM 990, PART VII Jonathan R. Behr, Managing Director of the T1D Fund is a key employee of JDRF. The compensation reported on Part VII represents one month of calendar year 2016. |
Schedule R IRS990ScheduleR
Id Disregarded Entities IdDisregardedEntitiesGrp
Disregarded Entity Name DisregardedEntityName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | JDRF T1D FUND LLC | BusinessNameLine1Txt |
US Address USAddress
| Field | Value | IRS element (for citing) |
|---|---|---|
| Address Line1 | C/O JDRF - 26 BROADWAY 14TH FLOOR | AddressLine1Txt |
| City | NEW YORK | CityNm |
| State Abbreviation | NY | StateAbbreviationCd |
| ZIP | 10004 | ZIPCd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| EIN | 274967989 | EIN |
| Primary Activities | FUNDR/INVEST | PrimaryActivitiesTxt |
| Legal Domicile State | DE | LegalDomicileStateCd |
| Total Income | $12,612,251 | TotalIncomeAmt |
| End Of Year Assets | $23,641,793 | EndOfYearAssetsAmt |
Direct Controlling Entity Name DirectControllingEntityName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | JDRF | BusinessNameLine1Txt |
Id Related Org Txbl Corp Tr IdRelatedOrgTxblCorpTrGrp
Related Organization Name RelatedOrganizationName
| Field | Value | IRS element (for citing) |
|---|---|---|
| Business Name Line1 | CHARITABLE REMAINDER TRUST (5) | BusinessNameLine1Txt |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Primary Activities | ANNUITY | PrimaryActivitiesTxt |
| Legal Domicile State | PA | LegalDomicileStateCd |
| Controlled Organization | Yes (true) | ControlledOrganizationInd |
| Field | Value | IRS element (for citing) |
|---|---|---|
| Receipt Of Int Annts Rnts Rylts | false | ReceiptOfIntAnntsRntsRyltsInd |
| Gift Grnt Or Cap Contri To Oth Org | false | GiftGrntOrCapContriToOthOrgInd |
| Gift Grnt Cap Contri From Oth Org | false | GiftGrntCapContriFromOthOrgInd |
| Loans Or Guarantees To Other Org | false | LoansOrGuaranteesToOtherOrgInd |
| Loans Or Guarantees From Oth Org | false | LoansOrGuaranteesFromOthOrgInd |
| Div Related Organization | false | DivRelatedOrganizationInd |
| Asset Sale To Other Org | false | AssetSaleToOtherOrgInd |
| Asset Purchase From Other Org | false | AssetPurchaseFromOtherOrgInd |
| Asset Exchange | false | AssetExchangeInd |
| Rental Of Facilities To Oth Org | false | RentalOfFacilitiesToOthOrgInd |
| Rental Of Fclts From Oth Org | false | RentalOfFcltsFromOthOrgInd |
| Perform Of Services For Oth Org | false | PerformOfServicesForOthOrgInd |
| Perform Of Services By Other Org | false | PerformOfServicesByOtherOrgInd |
| Sharing Of Facilities | false | SharingOfFacilitiesInd |
| Paid Employees Sharing | false | PaidEmployeesSharingInd |
| Reimbursement Paid To Other Org | false | ReimbursementPaidToOtherOrgInd |
| Reimbursement Paid By Other Org | false | ReimbursementPaidByOtherOrgInd |
| Transfer To Other Org | false | TransferToOtherOrgInd |
| Transfer From Other Org | false | TransferFromOtherOrgInd |
Supplemental Information Detail SupplementalInformationDetail
| Field | Value | IRS element (for citing) |
|---|---|---|
| Form And Line Reference | SCHEDULE R, PART I, LINE (1B) | FormAndLineReferenceDesc |
| Explanation | THE PRIMARY ACTIVITY FOR THE JDRF T1D FUND IS FUNDRAISING AND INVESTING IN TYPE ONE DIABETES RESEARCH. PLEASE SEE DETAILED DESCRIPTION ON SCHEDULE O, PART III, LINE 4A, STATEMENT OF PROGRAM SERVICE ACCOMPLISHMENTS FOR RESEARCH GRANTS. | ExplanationTxt |
Comments